ONTOLOGY REPORT - ANNOTATIONS
| Term: | 5-aza-2'-deoxycytidine |
|
| Accession: | CHEBI:50131
|
browse the term
|
| Definition: | A 2'-deoxyribonucleoside that has formula C8H12N4O4. |
| Synonyms: | exact_synonym: | 4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one |
| | related_synonym: | 4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-s-triazin-2(1H)-one; 5-azadeoxycytidine; C8H12N4O4; InChI=1S/C8H12N4O4/c9-7-10-3-12(8(15)11-7)6-1-4(14)5(2-13)16-6/h3-6,13-14H,1-2H2,(H2,9,11,15)/t4-,5+,6+/m0/s1; InChIKey=XAUDJQYHKZQPEU-KVQBGUIXSA-N; Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1; decitabine |
| | xref_casrn: | 2353-33-5 |
| | xref: | Beilstein:617982 "Beilstein Registry Number"; ChEMBL:775080 "ChEMBL COMPOUND"; ChemIDplus:2353-33-5 "CAS Registry Number"; DrugBank:DB01262 "DrugBank" |
| | xref_mesh: | MESH:C014347 |
| | xref: | Wikipedia:Decitabine "Wikipedia" |
|
|
5-aza-2'-deoxycytidine
|
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcc5 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 5 |
|
increases expression |
ISO |
11 |
82,714,334 |
82,809,354 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
affects expression |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
multiple interactions |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abt1 |
activator of basal transcription 1 |
|
decreases methylation |
ISO |
17 |
48,901,759 |
48,903,853 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
increases expression |
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:6480464 |
CTD |
| G |
Acp5 |
acid phosphatase 5, tartrate resistant |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Actn1 |
actinin, alpha 1 |
|
affects methylation |
ISO |
6 |
103,188,593 |
103,282,873 |
RGD:6480464 |
CTD |
| G |
Adamdec1 |
ADAM-like, decysin 1 |
|
increases expression |
ISO |
15 |
48,250,970 |
48,272,395 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
increases expression |
ISO |
11 |
25,434,262 |
25,443,144 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenoceptor alpha 1D |
|
affects methylation |
ISO |
3 |
119,279,974 |
119,295,985 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenoceptor alpha 1D |
|
multiple interactions |
ISO |
3 |
119,279,974 |
119,295,985 |
RGD:6480464 |
CTD |
| G |
Adra1d |
adrenoceptor alpha 1D |
|
increases expression |
ISO |
3 |
119,279,974 |
119,295,985 |
RGD:6480464 |
CTD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
decreases methylation |
EXP |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
increases expression |
EXP |
1 |
263,025,655 |
263,027,055 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
affects expression |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Aebp1 |
AE binding protein 1 |
|
affects expression |
ISO |
14 |
86,525,748 |
86,535,664 |
RGD:6480464 |
CTD |
| G |
Aebp1 |
AE binding protein 1 |
|
multiple interactions |
EXP |
14 |
86,525,748 |
86,535,664 |
RGD:6480464 |
CTD |
| G |
Agpat2 |
1-acylglycerol-3-phosphate O-acyltransferase 2 |
|
increases expression |
ISO |
3 |
4,769,863 |
4,781,045 |
RGD:6480464 |
CTD |
| G |
Agrn |
agrin |
|
multiple interactions |
ISO |
5 |
172,999,420 |
173,020,764 |
RGD:6480464 |
CTD |
| G |
Ak4 |
adenylate kinase 4 |
|
multiple interactions |
ISO |
5 |
122,062,872 |
122,119,335 |
RGD:6480464 |
CTD |
| G |
Ak4 |
adenylate kinase 4 |
|
decreases expression |
ISO |
5 |
122,062,872 |
122,119,335 |
RGD:6480464 |
CTD |
| G |
Akap12 |
A kinase (PRKA) anchor protein 12 |
|
affects methylation |
ISO |
1 |
34,979,039 |
35,068,763 |
RGD:6480464 |
CTD |
| G |
Akap12 |
A kinase (PRKA) anchor protein 12 |
|
multiple interactions |
ISO |
1 |
34,979,039 |
35,068,763 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases activity |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
|
affects expression |
ISO |
1 |
120,847,746 |
120,881,883 |
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
|
increases expression |
ISO |
1 |
120,847,746 |
120,881,883 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
increases expression |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
|
decreases expression |
ISO |
6 |
108,495,781 |
108,516,414 |
RGD:6480464 |
CTD |
| G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
|
multiple interactions |
ISO |
6 |
108,495,781 |
108,516,414 |
RGD:6480464 |
CTD |
| G |
Aldoc |
aldolase C, fructose-bisphosphate |
|
increases expression |
ISO |
10 |
64,308,826 |
64,312,415 |
RGD:6480464 |
CTD |
| G |
Alox12b |
arachidonate 12-lipoxygenase, 12R type |
|
multiple interactions |
ISO |
10 |
55,917,373 |
55,926,321 |
RGD:6480464 |
CTD |
| G |
Alox12b |
arachidonate 12-lipoxygenase, 12R type |
|
decreases expression |
ISO |
10 |
55,917,373 |
55,926,321 |
RGD:6480464 |
CTD |
| G |
Amh |
anti-Mullerian hormone |
|
decreases expression |
ISO |
7 |
10,417,325 |
10,419,673 |
RGD:6480464 |
CTD |
| G |
Amh |
anti-Mullerian hormone |
|
multiple interactions |
ISO |
7 |
10,417,325 |
10,419,673 |
RGD:6480464 |
CTD |
| G |
Amn1 |
antagonist of mitotic exit network 1 homolog (S. cerevisiae) |
|
multiple interactions |
EXP |
4 |
186,585,328 |
186,612,239 |
RGD:6480464 |
CTD |
| G |
Angpt2 |
angiopoietin 2 |
|
increases expression |
ISO |
16 |
75,891,757 |
75,942,255 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
increases expression |
ISO |
7 |
16,261,623 |
16,267,852 |
RGD:6480464 |
CTD |
| G |
Anpep |
alanyl (membrane) aminopeptidase |
|
multiple interactions |
ISO |
1 |
135,600,751 |
135,619,208 |
RGD:6480464 |
CTD |
| G |
Anpep |
alanyl (membrane) aminopeptidase |
|
increases expression |
ISO |
1 |
135,600,751 |
135,619,208 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
multiple interactions |
ISO |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
multiple interactions |
ISO |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Anxa4 |
annexin A4 |
|
multiple interactions |
ISO |
4 |
120,889,617 |
120,947,662 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
multiple interactions |
ISO |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
increases expression |
ISO |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Anxa6 |
annexin A6 |
|
multiple interactions |
ISO |
10 |
40,383,975 |
40,439,683 |
RGD:6480464 |
CTD |
| G |
Ap1s1 |
adaptor-related protein complex 1, sigma 1 subunit |
|
increases expression |
ISO |
12 |
20,907,855 |
20,918,301 |
RGD:6480464 |
CTD |
| G |
Ap1s2 |
adaptor-related protein complex 1, sigma 2 subunit |
|
increases expression |
ISO |
X |
51,329,574 |
51,356,406 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
affects expression |
ISO |
7 |
27,932,908 |
28,020,533 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
increases expression |
ISO |
7 |
27,932,908 |
28,020,533 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
increases expression |
ISO |
7 |
27,932,908 |
28,020,533 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
multiple interactions |
ISO |
7 |
27,932,908 |
28,020,533 |
RGD:6480464 |
CTD |
| G |
Apc |
adenomatous polyposis coli |
|
affects methylation |
ISO |
18 |
26,732,147 |
26,790,383 |
RGD:6480464 |
CTD |
| G |
Apc |
adenomatous polyposis coli |
|
decreases methylation |
ISO |
18 |
26,732,147 |
26,790,383 |
RGD:6480464 |
CTD |
| G |
Aplp2 |
amyloid beta (A4) precursor-like protein 2 |
|
affects methylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Aplp2 |
amyloid beta (A4) precursor-like protein 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apobec3b |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B |
|
multiple interactions |
ISO |
7 |
118,121,580 |
118,140,691 |
RGD:6480464 |
CTD |
| G |
Apod |
apolipoprotein D |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases expression |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases expression |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases methylation |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
increases expression |
ISO |
14 |
18,466,313 |
18,475,571 |
RGD:6480464 |
CTD |
| G |
Arhgap27 |
Rho GTPase activating protein 27 |
|
multiple interactions |
ISO |
10 |
92,522,546 |
92,551,340 |
RGD:6480464 |
CTD |
| G |
Arhgap29 |
Rho GTPase activating protein 29 |
|
affects methylation |
ISO |
2 |
218,619,428 |
218,679,087 |
RGD:6480464 |
CTD |
| G |
Arhgef6 |
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
|
increases expression |
ISO |
X |
141,946,362 |
142,068,557 |
RGD:6480464 |
CTD |
| G |
Arhgef6 |
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
|
multiple interactions |
ISO |
X |
141,946,362 |
142,068,557 |
RGD:6480464 |
CTD |
| G |
Arl4d |
ADP-ribosylation factor-like 4D |
|
increases expression |
ISO |
10 |
90,700,469 |
90,702,625 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
increases expression |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
multiple interactions |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
affects localization |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
affects response to substance |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
affects methylation |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
multiple interactions |
ISO |
13 |
80,214,056 |
80,234,576 |
RGD:6480464 |
CTD |
| G |
Atp1b2 |
ATPase, Na+/K+ transporting, beta 2 polypeptide |
|
multiple interactions |
ISO |
10 |
56,418,323 |
56,424,465 |
RGD:6480464 |
CTD |
| G |
Atp1b2 |
ATPase, Na+/K+ transporting, beta 2 polypeptide |
|
multiple interactions |
ISO |
10 |
56,418,323 |
56,424,465 |
RGD:6480464 |
CTD |
| G |
Atp5b |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
|
multiple interactions |
ISO |
7 |
1,376,552 |
1,383,228 |
RGD:6480464 |
CTD |
| G |
Axl |
Axl receptor tyrosine kinase |
|
multiple interactions |
ISO |
1 |
80,964,751 |
80,994,300 |
RGD:6480464 |
CTD |
| G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
|
multiple interactions |
ISO |
12 |
17,492,913 |
17,498,949 |
RGD:6480464 |
CTD |
| G |
Azi2 |
5-azacytidine induced 2 |
|
multiple interactions |
ISO |
8 |
122,961,302 |
122,985,601 |
RGD:6480464 |
CTD |
| G |
B2m |
beta-2 microglobulin |
|
increases expression |
ISO |
3 |
108,927,919 |
108,932,718 |
RGD:6480464 |
CTD |
| G |
B3galnt1 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
|
affects expression |
ISO |
2 |
159,670,705 |
159,701,464 |
RGD:6480464 |
CTD |
| G |
Bag2 |
Bcl2-associated athanogene 2 |
|
decreases expression |
ISO |
9 |
32,491,167 |
32,493,678 |
RGD:6480464 |
CTD |
| G |
Bag2 |
Bcl2-associated athanogene 2 |
|
multiple interactions |
ISO |
9 |
32,491,167 |
32,493,678 |
RGD:6480464 |
CTD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
increases expression |
ISO |
20 |
5,255,954 |
5,264,593 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bbc3 |
Bcl-2 binding component 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bbc3 |
Bcl-2 binding component 3 |
|
affects methylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
decreases methylation |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases expression |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
multiple interactions |
ISO |
10 |
90,317,957 |
90,333,329 |
RGD:6480464 |
CTD |
| G |
Bhmt2 |
betaine-homocysteine S-methyltransferase 2 |
|
multiple interactions |
ISO |
2 |
23,958,062 |
23,976,438 |
RGD:6480464 |
CTD |
| G |
Bhmt2 |
betaine-homocysteine S-methyltransferase 2 |
|
increases expression |
ISO |
2 |
23,958,062 |
23,976,438 |
RGD:6480464 |
CTD |
| G |
Bik |
BCL2-interacting killer (apoptosis-inducing) |
|
multiple interactions |
ISO |
7 |
121,377,004 |
121,396,609 |
RGD:6480464 |
CTD |
| G |
Bik |
BCL2-interacting killer (apoptosis-inducing) |
|
increases expression |
ISO |
7 |
121,377,004 |
121,396,609 |
RGD:6480464 |
CTD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
affects expression |
ISO |
8 |
4,649,559 |
4,667,733 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
affects expression |
ISO |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases methylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bmf |
Bcl2 modifying factor |
|
multiple interactions |
ISO |
3 |
104,966,652 |
104,984,752 |
RGD:6480464 |
CTD |
| G |
Bmi1 |
Bmi1 polycomb ring finger oncogene |
|
multiple interactions |
ISO |
17 |
92,784,216 |
92,787,947 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
multiple interactions |
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bmp6 |
bone morphogenetic protein 6 |
|
multiple interactions |
ISO |
17 |
32,380,199 |
32,689,295 |
RGD:6480464 |
CTD |
| G |
Bmp7 |
bone morphogenetic protein 7 |
|
decreases methylation |
ISO |
3 |
163,723,429 |
163,799,567 |
RGD:6480464 |
CTD |
| G |
Bmp7 |
bone morphogenetic protein 7 |
|
increases expression |
ISO |
3 |
163,723,429 |
163,799,567 |
RGD:6480464 |
CTD |
| G |
Bnc1 |
basonuclin 1 |
|
affects expression |
ISO |
1 |
138,189,334 |
138,201,795 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
multiple interactions |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
increases expression |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
decreases methylation |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
multiple interactions |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
decreases expression |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
|
affects methylation |
ISO |
15 |
46,516,626 |
46,539,756 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
affects localization |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Brf2 |
BRF2, RNA polymerase III transcription initiation factor 50 subunit |
|
increases expression |
ISO |
16 |
69,250,416 |
69,255,138 |
RGD:6480464 |
CTD |
| G |
Bsn |
bassoon (presynaptic cytomatrix protein) |
|
decreases expression |
ISO |
8 |
113,364,208 |
113,455,766 |
RGD:6480464 |
CTD |
| G |
Bsn |
bassoon (presynaptic cytomatrix protein) |
|
multiple interactions |
ISO |
8 |
113,364,208 |
113,455,766 |
RGD:6480464 |
CTD |
| G |
Bst2 |
bone marrow stromal cell antigen 2 |
|
affects expression |
ISO |
16 |
18,698,545 |
18,701,768 |
RGD:6480464 |
CTD |
| G |
Btg3 |
BTG family, member 3 |
|
decreases methylation |
ISO |
11 |
17,241,627 |
17,257,740 |
RGD:6480464 |
CTD |
| G |
Btg3 |
BTG family, member 3 |
|
increases expression |
ISO |
11 |
17,241,627 |
17,257,740 |
RGD:6480464 |
CTD |
| G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
|
multiple interactions |
ISO |
3 |
105,063,018 |
105,116,145 |
RGD:6480464 |
CTD |
| G |
C1qtnf6 |
C1q and tumor necrosis factor related protein 6 |
|
multiple interactions |
ISO |
7 |
116,479,791 |
116,486,309 |
RGD:6480464 |
CTD |
| G |
C1rl |
complement component 1, r subcomponent-like |
|
increases expression |
ISO |
4 |
160,694,113 |
160,708,614 |
RGD:6480464 |
CTD |
| G |
Cables1 |
Cdk5 and Abl enzyme substrate 1 |
|
affects methylation |
ISO |
18 |
3,425,890 |
3,529,998 |
RGD:6480464 |
CTD |
| G |
Cadm1 |
cell adhesion molecule 1 |
|
affects expression |
ISO |
8 |
50,765,645 |
51,108,962 |
RGD:6480464 |
CTD |
| G |
Cage1 |
cancer antigen 1 |
|
multiple interactions |
ISO |
17 |
33,017,106 |
33,056,422 |
RGD:6480464 |
CTD |
| G |
Camta2 |
calmodulin binding transcription activator 2 |
|
increases expression |
ISO |
10 |
57,549,855 |
57,567,958 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2, (m/II) large subunit |
|
multiple interactions |
ISO |
13 |
98,473,367 |
98,524,463 |
RGD:6480464 |
CTD |
| G |
Capn3 |
calpain 3 |
|
decreases expression |
ISO |
3 |
106,946,878 |
106,998,274 |
RGD:6480464 |
CTD |
| G |
Capn5 |
calpain 5 |
|
decreases expression |
ISO |
1 |
155,366,678 |
155,421,183 |
RGD:6480464 |
CTD |
| G |
Capn5 |
calpain 5 |
|
multiple interactions |
ISO |
1 |
155,366,678 |
155,421,183 |
RGD:6480464 |
CTD |
| G |
Car12 |
carbonic anyhydrase 12 |
|
increases expression |
ISO |
8 |
71,017,732 |
71,070,729 |
RGD:6480464 |
CTD |
| G |
Carhsp1 |
calcium regulated heat stable protein 1 |
|
increases expression |
ISO |
10 |
6,986,583 |
7,000,181 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
increases expression |
ISO |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases cleavage |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases expression |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
decreases methylation |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases expression |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases cleavage |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
increases expression |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Ccdc18 |
coiled-coil domain containing 18 |
|
multiple interactions |
ISO |
14 |
2,052,777 |
2,153,204 |
RGD:6480464 |
CTD |
| G |
Ccdc18 |
coiled-coil domain containing 18 |
|
decreases expression |
ISO |
14 |
2,052,777 |
2,153,204 |
RGD:6480464 |
CTD |
| G |
Cck |
cholecystokinin |
|
increases expression |
ISO |
8 |
126,492,636 |
126,499,220 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
increases expression |
ISO |
9 |
82,440,965 |
82,443,542 |
RGD:6480464 |
CTD |
| G |
Ccna1 |
cyclin A1 |
|
affects methylation |
ISO |
2 |
144,275,211 |
144,285,196 |
RGD:6480464 |
CTD |
| G |
Ccna1 |
cyclin A1 |
|
affects expression |
ISO |
2 |
144,275,211 |
144,285,196 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
affects methylation |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
decreases expression |
ISO |
10 |
13,474,659 |
13,500,979 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
multiple interactions |
ISO |
10 |
13,474,659 |
13,500,979 |
RGD:6480464 |
CTD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
increases expression |
ISO |
8 |
128,892,784 |
128,893,905 |
RGD:6480464 |
CTD |
| G |
Ccr4 |
chemokine (C-C motif) receptor 4 |
|
affects expression |
ISO |
8 |
118,883,148 |
118,884,230 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
multiple interactions |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
multiple interactions |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
increases expression |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd24 |
CD24 molecule |
|
increases expression |
ISO |
20 |
47,502,354 |
47,507,663 |
RGD:6480464 |
CTD |
| G |
Cd4 |
Cd4 molecule |
|
increases expression |
ISO |
4 |
160,988,512 |
161,014,038 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
increases expression |
ISO |
3 |
156,092,602 |
156,107,427 |
RGD:6480464 |
CTD |
| G |
Cd69 |
Cd69 molecule |
|
affects expression |
ISO |
4 |
166,527,683 |
166,535,601 |
RGD:6480464 |
CTD |
| G |
Cd80 |
Cd80 molecule |
|
increases expression |
ISO |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 molecule |
|
multiple interactions |
ISO |
4 |
162,279,462 |
162,312,889 |
RGD:6480464 |
CTD |
| G |
Cda |
cytidine deaminase |
|
increases degradation |
ISO |
5 |
157,117,303 |
157,143,989 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
decreases expression |
ISO |
18 |
27,206,537 |
27,225,811 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
multiple interactions |
ISO |
18 |
27,206,537 |
27,225,811 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
affects expression |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
affects methylation |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
decreases methylation |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
multiple interactions |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
multiple interactions |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
multiple interactions |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
decreases expression |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh11 |
cadherin 11 |
|
decreases expression |
ISO |
19 |
2,225,209 |
2,382,805 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
multiple interactions |
ISO |
19 |
48,507,173 |
49,575,123 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
multiple interactions |
ISO |
19 |
48,507,173 |
49,575,123 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
decreases methylation |
ISO |
19 |
48,507,173 |
49,575,123 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
increases expression |
ISO |
18 |
8,048,920 |
8,267,974 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
affects methylation |
EXP |
18 |
8,048,920 |
8,267,974 |
RGD:6480464 |
CTD |
| G |
Cdh8 |
cadherin 8 |
|
affects expression |
ISO |
19 |
5,685,862 |
6,014,208 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases phosphorylation |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk15 |
cyclin-dependent kinase 15 |
|
decreases expression |
ISO |
9 |
57,840,625 |
57,930,096 |
RGD:6480464 |
CTD |
| G |
Cdk15 |
cyclin-dependent kinase 15 |
|
multiple interactions |
ISO |
9 |
57,840,625 |
57,930,096 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
affects expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases methylation |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
affects expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
affects expression |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
multiple interactions |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
multiple interactions |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
increases expression |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
affects expression |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
affects methylation |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
affects methylation |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
decreases methylation |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
decreases methylation |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases expression |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases expression |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases expression |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
affects expression |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
affects expression |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
affects methylation |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
multiple interactions |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
multiple interactions |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
decreases methylation |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
decreases methylation |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
increases expression |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdx1 |
caudal type homeo box 1 |
|
increases expression |
ISO |
18 |
56,983,284 |
57,006,721 |
RGD:6480464 |
CTD |
| G |
Cdx2 |
caudal type homeo box 2 |
|
multiple interactions |
ISO |
12 |
8,296,103 |
8,303,643 |
RGD:6480464 |
CTD |
| G |
Cdx2 |
caudal type homeo box 2 |
|
decreases methylation |
ISO |
12 |
8,296,103 |
8,303,643 |
RGD:6480464 |
CTD |
| G |
Cdx2 |
caudal type homeo box 2 |
|
multiple interactions |
ISO |
12 |
8,296,103 |
8,303,643 |
RGD:6480464 |
CTD |
| G |
Cdx2 |
caudal type homeo box 2 |
|
increases expression |
ISO |
12 |
8,296,103 |
8,303,643 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases methylation |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
affects methylation |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
affects methylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cenpf |
centromere protein F |
|
decreases expression |
ISO |
13 |
105,920,242 |
105,965,655 |
RGD:6480464 |
CTD |
| G |
Cenpf |
centromere protein F |
|
multiple interactions |
ISO |
13 |
105,920,242 |
105,965,655 |
RGD:6480464 |
CTD |
| G |
Cep57 |
centrosomal protein 57 |
|
multiple interactions |
ISO |
8 |
10,608,688 |
10,627,914 |
RGD:6480464 |
CTD |
| G |
Cep57 |
centrosomal protein 57 |
|
decreases expression |
ISO |
8 |
10,608,688 |
10,627,914 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
affects expression |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Chd6 |
chromodomain helicase DNA binding protein 6 |
|
multiple interactions |
ISO |
3 |
151,741,389 |
151,924,668 |
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
affects localization |
ISO |
8 |
37,954,322 |
37,974,748 |
RGD:6480464 |
CTD |
| G |
Chfr |
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
12 |
46,651,265 |
46,684,689 |
RGD:6480464 |
CTD |
| G |
Chp |
calcium binding protein p22 |
|
affects methylation |
ISO |
3 |
106,066,389 |
106,101,635 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DFFA-like effector a |
|
multiple interactions |
ISO |
18 |
63,871,538 |
63,896,975 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DFFA-like effector a |
|
decreases methylation |
ISO |
18 |
63,871,538 |
63,896,975 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DFFA-like effector a |
|
increases expression |
ISO |
18 |
63,871,538 |
63,896,975 |
RGD:6480464 |
CTD |
| G |
Ciita |
class II, major histocompatibility complex, transactivator |
|
multiple interactions |
ISO |
10 |
5,087,174 |
5,133,418 |
RGD:6480464 |
CTD |
| G |
Cited1 |
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
|
increases expression |
ISO |
X |
90,301,067 |
90,305,762 |
RGD:6480464 |
CTD |
| G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
|
increases expression |
ISO |
1 |
206,802,745 |
206,806,332 |
RGD:6480464 |
CTD |
| G |
Clcn2 |
chloride channel, voltage-sensitive 2 |
|
increases expression |
ISO |
11 |
82,427,792 |
82,441,293 |
RGD:6480464 |
CTD |
| G |
Clcn2 |
chloride channel, voltage-sensitive 2 |
|
multiple interactions |
ISO |
11 |
82,427,792 |
82,441,293 |
RGD:6480464 |
CTD |
| G |
Cldn2 |
claudin 2 |
|
increases expression |
ISO |
X |
127,538,685 |
127,549,019 |
RGD:6480464 |
CTD |
| G |
Cldn3 |
claudin 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cldn3 |
claudin 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cldn3 |
claudin 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Clic1 |
chloride intracellular channel 1 |
|
decreases expression |
ISO |
20 |
3,498,935 |
3,842,500 |
RGD:6480464 |
CTD |
| G |
Cltc |
clathrin, heavy chain (Hc) |
|
affects methylation |
ISO |
10 |
74,976,825 |
75,032,529 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
multiple interactions |
ISO |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
increases expression |
ISO |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
decreases methylation |
ISO |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
multiple interactions |
ISO |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Cml1 |
camello-like 1 |
|
multiple interactions |
ISO |
4 |
120,059,311 |
120,065,996 |
RGD:6480464 |
CTD |
| G |
Cml1 |
camello-like 1 |
|
increases expression |
ISO |
4 |
120,059,311 |
120,065,996 |
RGD:6480464 |
CTD |
| G |
Cntn2 |
contactin 2 (axonal) |
|
affects expression |
ISO |
13 |
45,399,915 |
45,428,789 |
RGD:6480464 |
CTD |
| G |
Cntrl |
centriolin |
|
decreases expression |
ISO |
3 |
14,168,983 |
14,242,139 |
RGD:6480464 |
CTD |
| G |
Cntrl |
centriolin |
|
multiple interactions |
ISO |
3 |
14,168,983 |
14,242,139 |
RGD:6480464 |
CTD |
| G |
Cog8 |
component of oligomeric golgi complex 8 |
|
multiple interactions |
ISO |
19 |
36,904,222 |
36,914,972 |
RGD:6480464 |
CTD |
| G |
Col14a1 |
collagen, type XIV, alpha 1 |
|
increases expression |
ISO |
7 |
91,801,534 |
92,032,966 |
RGD:6480464 |
CTD |
| G |
Col17a1 |
collagen, type XVII, alpha 1 |
|
increases expression |
ISO |
1 |
253,012,167 |
253,059,385 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
decreases methylation |
ISO |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
increases expression |
ISO |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col22a1 |
collagen, type XXII, alpha 1 |
|
multiple interactions |
ISO |
7 |
109,509,148 |
109,727,220 |
RGD:6480464 |
CTD |
| G |
Col8a2 |
collagen, type VIII, alpha 2 |
|
increases expression |
ISO |
5 |
145,679,681 |
145,684,323 |
RGD:6480464 |
CTD |
| G |
Cpa3 |
carboxypeptidase A3, mast cell |
|
increases expression |
ISO |
2 |
105,368,835 |
105,402,657 |
RGD:6480464 |
CTD |
| G |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
|
affects expression |
ISO |
1 |
137,556,766 |
137,666,929 |
RGD:6480464 |
CTD |
| G |
Crabp1 |
cellular retinoic acid binding protein 1 |
|
affects methylation |
ISO |
8 |
58,317,337 |
58,325,375 |
RGD:6480464 |
CTD |
| G |
Crabp1 |
cellular retinoic acid binding protein 1 |
|
multiple interactions |
ISO |
8 |
58,317,337 |
58,325,375 |
RGD:6480464 |
CTD |
| G |
Crisp2 |
cysteine-rich secretory protein 2 |
|
increases expression |
ISO |
9 |
16,247,687 |
16,271,947 |
RGD:6480464 |
CTD |
| G |
Crocc |
ciliary rootlet coiled-coil, rootletin |
|
increases expression |
ISO |
5 |
159,875,186 |
159,896,308 |
RGD:6480464 |
CTD |
| G |
Csnk2a1 |
casein kinase 2, alpha 1 polypeptide |
|
increases expression |
ISO |
3 |
142,564,754 |
142,609,311 |
RGD:6480464 |
CTD |
| G |
Csnk2a1 |
casein kinase 2, alpha 1 polypeptide |
|
increases activity |
ISO |
3 |
142,564,754 |
142,609,311 |
RGD:6480464 |
CTD |
| G |
Csnk2a2 |
casein kinase 2, alpha prime polypeptide |
|
increases expression |
ISO |
19 |
10,015,369 |
10,054,662 |
RGD:6480464 |
CTD |
| G |
Cst3 |
cystatin C |
|
multiple interactions |
ISO |
3 |
137,650,903 |
137,654,776 |
RGD:6480464 |
CTD |
| G |
Cst6 |
cystatin E/M |
|
affects expression |
ISO |
1 |
207,991,313 |
207,993,021 |
RGD:6480464 |
CTD |
| G |
Cst6 |
cystatin E/M |
|
increases expression |
ISO |
1 |
207,991,313 |
207,993,021 |
RGD:6480464 |
CTD |
| G |
Cst7 |
cystatin F (leukocystatin) |
|
increases expression |
ISO |
3 |
141,188,442 |
141,199,756 |
RGD:6480464 |
CTD |
| G |
Ctcf |
CCCTC-binding factor (zinc finger protein) |
|
multiple interactions |
ISO |
19 |
35,461,942 |
35,514,934 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
increases expression |
ISO |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
increases expression |
ISO |
9 |
59,495,773 |
59,501,300 |
RGD:6480464 |
CTD |
| G |
Ctnna1 |
catenin (cadherin-associated protein), alpha 1, 102kDa |
|
multiple interactions |
ISO |
18 |
27,629,915 |
27,769,360 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases response to substance |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
affects localization |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctsh |
cathepsin H |
|
multiple interactions |
ISO |
8 |
94,971,689 |
94,990,434 |
RGD:6480464 |
CTD |
| G |
Ctsh |
cathepsin H |
|
increases expression |
ISO |
8 |
94,971,689 |
94,990,434 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
increases expression |
ISO |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Ctsz |
cathepsin Z |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ctsz |
cathepsin Z |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cxadr |
coxsackie virus and adenovirus receptor |
|
multiple interactions |
ISO |
11 |
17,193,505 |
17,241,549 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
affects methylation |
ISO |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
increases expression |
ISO |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
decreases methylation |
ISO |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl14 |
chemokine (C-X-C motif) ligand 14 |
|
decreases methylation |
ISO |
17 |
14,286,747 |
14,295,502 |
RGD:6480464 |
CTD |
| G |
Cxcl14 |
chemokine (C-X-C motif) ligand 14 |
|
increases expression |
ISO |
17 |
14,286,747 |
14,295,502 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
decreases methylation |
ISO |
14 |
18,825,357 |
18,826,269 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
increases expression |
ISO |
14 |
18,825,357 |
18,826,269 |
RGD:6480464 |
CTD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
affects methylation |
ISO |
14 |
17,284,085 |
17,288,996 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
affects expression |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
multiple interactions |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
multiple interactions |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cyld |
cylindromatosis (turban tumor syndrome) |
|
multiple interactions |
ISO |
19 |
19,616,209 |
19,619,221 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
affects methylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
affects expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
affects methylation |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Dact1 |
dishevelled-binding antagonist of beta-catenin 1 |
|
multiple interactions |
ISO |
6 |
93,402,304 |
93,411,668 |
RGD:6480464 |
CTD |
| G |
Dact2 |
dishevelled-binding antagonist of beta-catenin 2 |
|
multiple interactions |
ISO |
1 |
53,084,115 |
53,093,031 |
RGD:6480464 |
CTD |
| G |
Dact3 |
dishevelled-binding antagonist of beta-catenin 3 |
|
affects expression |
ISO |
1 |
77,201,808 |
77,213,537 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
affects expression |
ISO |
17 |
9,617,607 |
9,779,457 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
multiple interactions |
ISO |
17 |
9,617,607 |
9,779,457 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
decreases methylation |
ISO |
17 |
9,617,607 |
9,779,457 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
increases expression |
ISO |
17 |
9,617,607 |
9,779,457 |
RGD:6480464 |
CTD |
| G |
Dapk3 |
death-associated protein kinase 3 |
|
increases expression |
ISO |
7 |
10,007,997 |
10,016,365 |
RGD:6480464 |
CTD |
| G |
Dazl |
deleted in azoospermia-like |
|
increases expression |
ISO |
9 |
5,899,104 |
5,915,835 |
RGD:6480464 |
CTD |
| G |
Dbc1 |
deleted in bladder cancer 1 |
|
multiple interactions |
ISO |
5 |
86,070,267 |
86,216,181 |
RGD:6480464 |
CTD |
| G |
Dcbld2 |
discoidin, CUB and LCCL domain containing 2 |
|
multiple interactions |
ISO |
11 |
42,941,795 |
42,980,245 |
RGD:6480464 |
CTD |
| G |
Dcc |
deleted in colorectal carcinoma |
|
increases expression |
ISO |
18 |
68,026,795 |
69,140,741 |
RGD:6480464 |
CTD |
| G |
Dclk1 |
doublecortin-like kinase 1 |
|
affects expression |
ISO |
2 |
144,678,222 |
144,754,237 |
RGD:6480464 |
CTD |
| G |
Ddost |
dolichyl-diphosphooligosaccharide-protein glycosyltransferase |
|
affects methylation |
ISO |
5 |
157,083,337 |
157,090,071 |
RGD:6480464 |
CTD |
| G |
Dffb |
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) |
|
affects methylation |
ISO |
5 |
170,750,718 |
170,762,034 |
RGD:6480464 |
CTD |
| G |
Dhrs9 |
dehydrogenase/reductase (SDR family) member 9 |
|
increases expression |
ISO |
3 |
51,521,343 |
51,543,552 |
RGD:6480464 |
CTD |
| G |
Dip2c |
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
|
increases expression |
ISO |
17 |
71,435,930 |
71,824,903 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
|
multiple interactions |
ISO |
1 |
234,392,743 |
234,396,426 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
|
decreases methylation |
ISO |
1 |
234,392,743 |
234,396,426 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
|
increases expression |
ISO |
1 |
234,392,743 |
234,396,426 |
RGD:6480464 |
CTD |
| G |
Dlc1 |
deleted in liver cancer 1 |
|
affects methylation |
ISO |
16 |
59,312,930 |
59,355,129 |
RGD:6480464 |
CTD |
| G |
Dlk1 |
delta-like 1 homolog (Drosophila) |
|
decreases methylation |
ISO |
6 |
134,022,016 |
134,043,058 |
RGD:6480464 |
CTD |
| G |
Dlk1 |
delta-like 1 homolog (Drosophila) |
|
increases expression |
ISO |
6 |
134,022,016 |
134,043,058 |
RGD:6480464 |
CTD |
| G |
Dlx2 |
distal-less homeobox 2 |
|
increases expression |
ISO |
3 |
53,852,209 |
53,854,092 |
RGD:6480464 |
CTD |
| G |
Dmrtb1 |
DMRT-like family B with proline-rich C-terminal, 1 |
|
increases expression |
ISO |
5 |
128,780,184 |
128,787,016 |
RGD:6480464 |
CTD |
| G |
Dnaja4 |
DnaJ (Hsp40) homolog, subfamily A, member 4 |
|
increases expression |
ISO |
8 |
58,250,793 |
58,266,534 |
RGD:6480464 |
CTD |
| G |
Dnajb3 |
DnaJ (Hsp40) homolog, subfamily B, member 3 |
|
increases expression |
ISO |
9 |
87,085,458 |
87,086,471 |
RGD:6480464 |
CTD |
| G |
Dnajc12 |
DnaJ (Hsp40) homolog, subfamily C, member 12 |
|
decreases expression |
ISO |
20 |
25,729,728 |
25,751,389 |
RGD:6480464 |
CTD |
| G |
Dnajc15 |
DnaJ (Hsp40) homolog, subfamily C, member 15 |
|
affects expression |
ISO |
15 |
58,871,147 |
58,937,853 |
RGD:6480464 |
CTD |
| G |
Dnajc3 |
DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
multiple interactions |
ISO |
15 |
103,881,634 |
103,921,295 |
RGD:6480464 |
CTD |
| G |
Dnajc3 |
DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
decreases expression |
ISO |
15 |
103,881,634 |
103,921,295 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
increases degradation |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
decreases expression |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
decreases expression |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
multiple interactions |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
increases expression |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
decreases expression |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
affects response to substance |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
multiple interactions |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
affects response to substance |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA (cytosine-5-)-methyltransferase 3 alpha |
|
multiple interactions |
ISO |
6 |
26,802,612 |
26,878,878 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA (cytosine-5-)-methyltransferase 3 alpha |
|
decreases expression |
ISO |
6 |
26,802,612 |
26,878,878 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA (cytosine-5-)-methyltransferase 3 alpha |
|
multiple interactions |
ISO |
6 |
26,802,612 |
26,878,878 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA (cytosine-5-)-methyltransferase 3 alpha |
|
decreases expression |
ISO |
6 |
26,802,612 |
26,878,878 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
affects expression |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
decreases expression |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
multiple interactions |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
decreases expression |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
affects response to substance |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
decreases expression |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dok1 |
docking protein 1 |
|
increases expression |
ISO |
4 |
117,242,746 |
117,245,209 |
RGD:6480464 |
CTD |
| G |
Dok4 |
docking protein 4 |
|
increases expression |
ISO |
19 |
10,585,647 |
10,596,322 |
RGD:6480464 |
CTD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
affects expression |
ISO |
3 |
44,279,255 |
44,360,283 |
RGD:6480464 |
CTD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
decreases methylation |
ISO |
2 |
214,931,901 |
215,818,809 |
RGD:6480464 |
CTD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
increases expression |
ISO |
2 |
214,931,901 |
215,818,809 |
RGD:6480464 |
CTD |
| G |
Dsc3 |
desmocollin 3 |
|
affects expression |
ISO |
18 |
11,831,071 |
11,865,107 |
RGD:6480464 |
CTD |
| G |
Dspp |
dentin sialophosphoprotein |
|
increases expression |
ISO |
14 |
6,674,662 |
6,680,769 |
RGD:6480464 |
CTD |
| G |
Dusp2 |
dual specificity phosphatase 2 |
|
multiple interactions |
ISO |
3 |
114,838,605 |
114,840,790 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
affects expression |
ISO |
7 |
36,893,264 |
36,897,494 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
increases expression |
ISO |
7 |
36,893,264 |
36,897,494 |
RGD:6480464 |
CTD |
| G |
Dvl1 |
dishevelled segment polarity protein 1 |
|
multiple interactions |
ISO |
5 |
172,705,951 |
172,717,626 |
RGD:6480464 |
CTD |
| G |
Dynll1 |
dynein light chain LC8-type 1 |
|
increases expression |
ISO |
12 |
42,580,542 |
42,582,915 |
RGD:6480464 |
CTD |
| G |
Dysf |
dysferlin |
|
multiple interactions |
EXP |
4 |
118,213,435 |
118,371,283 |
RGD:6480464 |
CTD |
| G |
E2f6 |
E2F transcription factor 6 |
|
decreases expression |
ISO |
6 |
40,494,286 |
40,534,152 |
RGD:6480464 |
CTD |
| G |
Ebi3 |
Epstein-Barr virus induced 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
|
increases expression |
ISO |
3 |
170,295,327 |
170,304,505 |
RGD:6480464 |
CTD |
| G |
Efemp1 |
EGF-containing fibulin-like extracellular matrix protein 1 |
|
affects methylation |
ISO |
14 |
109,733,625 |
109,828,630 |
RGD:6480464 |
CTD |
| G |
Egfl7 |
EGF-like-domain, multiple 7 |
|
multiple interactions |
ISO |
3 |
4,760,574 |
4,769,909 |
RGD:6480464 |
CTD |
| G |
Egfl7 |
EGF-like-domain, multiple 7 |
|
increases expression |
ISO |
3 |
4,760,574 |
4,769,909 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Ehd3 |
EH-domain containing 3 |
|
multiple interactions |
ISO |
6 |
21,638,705 |
21,686,023 |
RGD:6480464 |
CTD |
| G |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
|
affects response to substance |
ISO |
20 |
4,021,679 |
4,033,709 |
RGD:6480464 |
CTD |
| G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
|
affects methylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Eif4g1 |
eukaryotic translation initiation factor 4 gamma, 1 |
|
increases expression |
ISO |
11 |
82,451,555 |
82,471,735 |
RGD:6480464 |
CTD |
| G |
Elavl1 |
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) |
|
multiple interactions |
ISO |
12 |
1,459,046 |
1,500,042 |
RGD:6480464 |
CTD |
| G |
Elavl3 |
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C) |
|
increases expression |
ISO |
8 |
21,124,168 |
21,158,232 |
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
multiple interactions |
ISO |
2 |
27,720,805 |
27,733,168 |
RGD:6480464 |
CTD |
| G |
Eng |
endoglin |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
increases expression |
ISO |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Eno2 |
enolase 2, gamma, neuronal |
|
multiple interactions |
ISO |
4 |
160,891,003 |
160,897,723 |
RGD:6480464 |
CTD |
| G |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
|
multiple interactions |
ISO |
15 |
58,555,747 |
58,762,870 |
RGD:6480464 |
CTD |
| G |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
|
decreases expression |
ISO |
15 |
58,555,747 |
58,762,870 |
RGD:6480464 |
CTD |
| G |
Ep300 |
E1A binding protein p300 |
|
affects methylation |
ISO |
7 |
119,938,507 |
120,008,886 |
RGD:6480464 |
CTD |
| G |
Ep300 |
E1A binding protein p300 |
|
multiple interactions |
ISO |
7 |
119,938,507 |
120,008,886 |
RGD:6480464 |
CTD |
| G |
Epb4.1 |
erythrocyte membrane protein band 4.1 |
|
affects expression |
ISO |
5 |
150,782,245 |
150,908,888 |
RGD:6480464 |
CTD |
| G |
Epb41l3 |
erythrocyte membrane protein band 4.1-like 3 |
|
affects expression |
ISO |
9 |
108,303,607 |
108,426,942 |
RGD:6480464 |
CTD |
| G |
Epcam |
epithelial cell adhesion molecule |
|
affects expression |
ISO |
6 |
11,176,664 |
11,192,628 |
RGD:6480464 |
CTD |
| G |
Epcam |
epithelial cell adhesion molecule |
|
multiple interactions |
ISO |
6 |
11,176,664 |
11,192,628 |
RGD:6480464 |
CTD |
| G |
Epha1 |
Eph receptor A1 |
|
decreases methylation |
ISO |
4 |
70,127,872 |
70,142,309 |
RGD:6480464 |
CTD |
| G |
Epha1 |
Eph receptor A1 |
|
increases expression |
ISO |
4 |
70,127,872 |
70,142,309 |
RGD:6480464 |
CTD |
| G |
Epha2 |
Eph receptor A2 |
|
affects methylation |
ISO |
5 |
160,185,143 |
160,214,727 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
ISO |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx3 |
epoxide hydrolase 3 |
|
increases expression |
ISO |
7 |
12,762,797 |
12,768,105 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
increases expression |
ISO |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Eral1 |
Era-like 12S mitochondrial rRNA chaperone 1 |
|
multiple interactions |
ISO |
10 |
64,129,729 |
64,137,047 |
RGD:6480464 |
CTD |
| G |
Eral1 |
Era-like 12S mitochondrial rRNA chaperone 1 |
|
increases expression |
ISO |
10 |
64,129,729 |
64,137,047 |
RGD:6480464 |
CTD |
| G |
Erg |
v-ets erythroblastosis virus E26 oncogene homolog (avian) |
|
decreases methylation |
ISO |
11 |
35,655,563 |
35,760,055 |
RGD:6480464 |
CTD |
| G |
Erg |
v-ets erythroblastosis virus E26 oncogene homolog (avian) |
|
increases expression |
ISO |
11 |
35,655,563 |
35,760,055 |
RGD:6480464 |
CTD |
| G |
Erg |
v-ets erythroblastosis virus E26 oncogene homolog (avian) |
|
increases expression |
ISO |
11 |
35,655,563 |
35,760,055 |
RGD:6480464 |
CTD |
| G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
|
increases expression |
ISO |
5 |
168,012,683 |
168,025,963 |
RGD:6480464 |
CTD |
| G |
Esam |
endothelial cell adhesion molecule |
|
increases expression |
ISO |
8 |
38,773,224 |
38,784,349 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases stability |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
decreases methylation |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
increases expression |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Ets1 |
v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) |
|
increases expression |
ISO |
8 |
32,481,694 |
32,545,237 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
increases expression |
ISO |
2 |
25,985,800 |
25,989,072 |
RGD:6480464 |
CTD |
| G |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
|
affects expression |
ISO |
2 |
25,886,177 |
25,899,128 |
RGD:6480464 |
CTD |
| G |
Fabp5 |
fatty acid binding protein 5, epidermal |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fads1 |
fatty acid desaturase 1 |
|
increases expression |
ISO |
1 |
212,670,792 |
212,685,718 |
RGD:6480464 |
CTD |
| G |
Fam111a |
family with sequence similarity 111, member A |
|
increases expression |
ISO |
1 |
215,581,410 |
215,597,220 |
RGD:6480464 |
CTD |
| G |
Fam149b1 |
family with sequence similarity 149, member B1 |
|
increases expression |
ISO |
15 |
4,157,828 |
4,196,419 |
RGD:6480464 |
CTD |
| G |
Fam29a |
family with sequence similarity 29, member A |
|
decreases expression |
ISO |
5 |
105,665,321 |
105,702,238 |
RGD:6480464 |
CTD |
| G |
Fam29a |
family with sequence similarity 29, member A |
|
multiple interactions |
ISO |
5 |
105,665,321 |
105,702,238 |
RGD:6480464 |
CTD |
| G |
Fam83a |
family with sequence similarity 83, member A |
|
multiple interactions |
ISO |
7 |
94,692,898 |
94,717,221 |
RGD:6480464 |
CTD |
| G |
Fam8a1 |
family with sequence similarity 8, member A1 |
|
increases expression |
ISO |
17 |
24,087,996 |
24,094,798 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
multiple interactions |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fbp1 |
fructose-1,6-bisphosphatase 1 |
|
multiple interactions |
ISO |
17 |
7,795,717 |
7,818,041 |
RGD:6480464 |
CTD |
| G |
Fbp2 |
fructose-1,6-bisphosphatase 2 |
|
multiple interactions |
ISO |
17 |
7,824,298 |
7,841,661 |
RGD:6480464 |
CTD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
increases expression |
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
decreases expression |
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:6480464 |
CTD |
| G |
Fhit |
fragile histidine triad |
|
affects methylation |
ISO |
15 |
15,823,461 |
17,329,184 |
RGD:6480464 |
CTD |
| G |
Fhit |
fragile histidine triad |
|
multiple interactions |
ISO |
15 |
15,823,461 |
17,329,184 |
RGD:6480464 |
CTD |
| G |
Fhit |
fragile histidine triad |
|
decreases methylation |
EXP |
15 |
15,823,461 |
17,329,184 |
RGD:6480464 |
CTD |
| G |
Fhit |
fragile histidine triad |
|
increases expression |
EXP |
15 |
15,823,461 |
17,329,184 |
RGD:6480464 |
CTD |
| G |
Fhl1 |
four and a half LIM domains 1 |
|
affects methylation |
ISO |
X |
141,315,765 |
141,329,278 |
RGD:6480464 |
CTD |
| G |
Fhl2 |
four and a half LIM domains 2 |
|
multiple interactions |
ISO |
9 |
42,319,997 |
42,349,055 |
RGD:6480464 |
CTD |
| G |
Filip1 |
filamin A interacting protein 1 |
|
increases expression |
ISO |
8 |
84,873,131 |
84,902,873 |
RGD:6480464 |
CTD |
| G |
Fkbp1b |
FK506 binding protein 1b |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Flt4 |
fms-related tyrosine kinase 4 |
|
increases expression |
ISO |
10 |
35,071,002 |
35,112,006 |
RGD:6480464 |
CTD |
| G |
Flt4 |
fms-related tyrosine kinase 4 |
|
multiple interactions |
ISO |
10 |
35,071,002 |
35,112,006 |
RGD:6480464 |
CTD |
| G |
Fmr1nb |
fragile X mental retardation 1 neighbor |
|
increases expression |
ISO |
X |
154,833,444 |
154,856,109 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
affects expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
affects methylation |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
increases expression |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Fosl2 |
fos-like antigen 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Foxa1 |
forkhead box A1 |
|
multiple interactions |
ISO |
6 |
77,976,384 |
78,009,176 |
RGD:6480464 |
CTD |
| G |
Foxj1 |
forkhead box J1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Foxk1 |
forkhead box K1 |
|
multiple interactions |
ISO |
12 |
12,513,060 |
12,568,394 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
multiple interactions |
ISO |
2 |
141,127,345 |
141,203,446 |
RGD:6480464 |
CTD |
| G |
Foxp3 |
forkhead box P3 |
|
multiple interactions |
ISO |
X |
26,950,006 |
26,965,329 |
RGD:6480464 |
CTD |
| G |
Foxp3 |
forkhead box P3 |
|
decreases methylation |
ISO |
X |
26,950,006 |
26,965,329 |
RGD:6480464 |
CTD |
| G |
Foxp3 |
forkhead box P3 |
|
multiple interactions |
ISO |
X |
26,950,006 |
26,965,329 |
RGD:6480464 |
CTD |
| G |
Foxp3 |
forkhead box P3 |
|
increases expression |
ISO |
X |
26,950,006 |
26,965,329 |
RGD:6480464 |
CTD |
| G |
Foxp3 |
forkhead box P3 |
|
increases expression |
ISO |
X |
26,950,006 |
26,965,329 |
RGD:6480464 |
CTD |
| G |
Fpr1 |
formyl peptide receptor 1 |
|
decreases expression |
ISO |
1 |
56,587,183 |
56,588,390 |
RGD:6480464 |
CTD |
| G |
Fpr1 |
formyl peptide receptor 1 |
|
multiple interactions |
ISO |
1 |
56,587,183 |
56,588,390 |
RGD:6480464 |
CTD |
| G |
Fsd1 |
fibronectin type III and SPRY domain containing 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fst |
follistatin |
|
increases expression |
ISO |
2 |
46,542,246 |
46,550,678 |
RGD:6480464 |
CTD |
| G |
Fstl1 |
follistatin-like 1 |
|
increases expression |
ISO |
11 |
64,681,814 |
64,735,673 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
increases expression |
ISO |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Fxyd6 |
FXYD domain-containing ion transport regulator 6 |
|
multiple interactions |
ISO |
8 |
48,323,818 |
48,371,958 |
RGD:6480464 |
CTD |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
affects expression |
ISO |
20 |
43,501,853 |
43,695,567 |
RGD:6480464 |
CTD |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
increases expression |
ISO |
20 |
43,501,853 |
43,695,567 |
RGD:6480464 |
CTD |
| G |
Fzd7 |
frizzled family receptor 7 |
|
multiple interactions |
ISO |
9 |
58,063,740 |
58,066,559 |
RGD:6480464 |
CTD |
| G |
Gabarapl1 |
GABA(A) receptor-associated protein like 1 |
|
affects expression |
ISO |
4 |
166,802,106 |
166,811,249 |
RGD:6480464 |
CTD |
| G |
Gabarapl1 |
GABA(A) receptor-associated protein like 1 |
|
increases expression |
ISO |
4 |
166,802,106 |
166,811,249 |
RGD:6480464 |
CTD |
| G |
Gabarapl1 |
GABA(A) receptor-associated protein like 1 |
|
multiple interactions |
ISO |
4 |
166,802,106 |
166,811,249 |
RGD:6480464 |
CTD |
| G |
Gabarapl1 |
GABA(A) receptor-associated protein like 1 |
|
decreases expression |
ISO |
4 |
166,802,106 |
166,811,249 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
increases expression |
ISO |
10 |
27,037,561 |
27,126,074 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
multiple interactions |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
decreases methylation |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
increases expression |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
decreases expression |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gas2l1 |
growth arrest-specific 2 like 1 |
|
multiple interactions |
ISO |
14 |
85,716,617 |
85,726,368 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
multiple interactions |
EXP |
16 |
80,900,159 |
80,930,929 |
RGD:6480464 |
CTD |
| G |
Gata1 |
GATA binding protein 1 |
|
multiple interactions |
ISO |
X |
26,564,259 |
26,572,081 |
RGD:6480464 |
CTD |
| G |
Gata2 |
GATA binding protein 2 |
|
multiple interactions |
ISO |
4 |
122,279,753 |
122,288,528 |
RGD:6480464 |
CTD |
| G |
Gata3 |
GATA binding protein 3 |
|
multiple interactions |
ISO |
17 |
79,991,587 |
80,011,574 |
RGD:6480464 |
CTD |
| G |
Gch1 |
GTP cyclohydrolase 1 |
|
increases expression |
ISO |
15 |
23,023,996 |
23,139,794 |
RGD:6480464 |
CTD |
| G |
Gdf10 |
growth differentiation factor 10 |
|
increases expression |
ISO |
16 |
9,558,781 |
9,570,656 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
affects expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
multiple interactions |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gfi1 |
growth factor independent 1 transcription repressor |
|
multiple interactions |
ISO |
14 |
2,597,303 |
2,606,681 |
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
affects expression |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
multiple interactions |
ISO |
X |
89,448,873 |
89,456,812 |
RGD:6480464 |
CTD |
| G |
Gjb3 |
gap junction protein, beta 3 |
|
decreases expression |
ISO |
5 |
146,771,804 |
146,772,616 |
RGD:6480464 |
CTD |
| G |
Gjc1 |
gap junction protein, gamma 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gk |
glycerol kinase |
|
decreases expression |
ISO |
X |
72,416,872 |
72,493,296 |
RGD:6480464 |
CTD |
| G |
Gldc |
glycine dehydrogenase (decarboxylating) |
|
increases expression |
ISO |
1 |
233,846,690 |
233,925,736 |
RGD:6480464 |
CTD |
| G |
Gli1 |
GLI family zinc finger 1 |
|
multiple interactions |
ISO |
7 |
67,288,291 |
67,297,461 |
RGD:6480464 |
CTD |
| G |
Gli2 |
GLI family zinc finger 2 |
|
decreases expression |
ISO |
13 |
31,551,089 |
31,607,264 |
RGD:6480464 |
CTD |
| G |
Gli2 |
GLI family zinc finger 2 |
|
multiple interactions |
ISO |
13 |
31,551,089 |
31,607,264 |
RGD:6480464 |
CTD |
| G |
Glipr1 |
GLI pathogenesis-related 1 |
|
affects methylation |
ISO |
7 |
51,081,712 |
51,092,707 |
RGD:6480464 |
CTD |
| G |
Gmds |
GDP-mannose 4, 6-dehydratase |
|
decreases expression |
ISO |
17 |
38,461,733 |
39,016,771 |
RGD:6480464 |
CTD |
| G |
Gnb2l1 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 like 1 |
|
multiple interactions |
ISO |
10 |
34,067,237 |
34,072,593 |
RGD:6480464 |
CTD |
| G |
Gnb2l1 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 like 1 |
|
decreases expression |
ISO |
10 |
34,067,237 |
34,072,593 |
RGD:6480464 |
CTD |
| G |
Got1l1 |
glutamic-oxaloacetic transaminase 1-like 1 |
|
increases expression |
ISO |
16 |
69,182,536 |
69,188,087 |
RGD:6480464 |
CTD |
| G |
Gpr162 |
G protein-coupled receptor 162 |
|
multiple interactions |
ISO |
4 |
160,980,644 |
160,986,565 |
RGD:6480464 |
CTD |
| G |
Gpr162 |
G protein-coupled receptor 162 |
|
decreases expression |
ISO |
4 |
160,980,644 |
160,986,565 |
RGD:6480464 |
CTD |
| G |
Gpr34 |
G protein-coupled receptor 34 |
|
affects expression |
ISO |
X |
21,117,225 |
21,124,903 |
RGD:6480464 |
CTD |
| G |
Gprc5b |
G protein-coupled receptor, family C, group 5, member B |
|
affects expression |
ISO |
1 |
177,205,905 |
177,230,442 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
multiple interactions |
ISO |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
increases expression |
ISO |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Gpx7 |
glutathione peroxidase 7 |
|
multiple interactions |
ISO |
5 |
129,506,986 |
129,514,830 |
RGD:6480464 |
CTD |
| G |
Grem1 |
gremlin 1 |
|
increases expression |
ISO |
3 |
99,597,201 |
99,608,935 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
multiple interactions |
ISO |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gstk1 |
glutathione S-transferase kappa 1 |
|
multiple interactions |
ISO |
4 |
69,999,767 |
70,004,086 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
multiple interactions |
ISO |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
increases expression |
ISO |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
multiple interactions |
ISO |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
multiple interactions |
ISO |
1 |
253,228,547 |
253,238,531 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
decreases methylation |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gtf2h1 |
general transcription factor IIH, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
97,352,251 |
97,380,298 |
RGD:6480464 |
CTD |
| G |
Gtpbp1 |
GTP binding protein 1 |
|
increases expression |
ISO |
7 |
117,934,168 |
117,957,660 |
RGD:6480464 |
CTD |
| G |
Gtpbp2 |
GTP binding protein 2 |
|
multiple interactions |
ISO |
9 |
10,377,808 |
10,385,845 |
RGD:6480464 |
CTD |
| G |
Gtpbp2 |
GTP binding protein 2 |
|
increases expression |
ISO |
9 |
10,377,808 |
10,385,845 |
RGD:6480464 |
CTD |
| G |
Gypc |
glycophorin C (Gerbich blood group) |
|
decreases expression |
ISO |
18 |
24,974,608 |
25,006,999 |
RGD:6480464 |
CTD |
| G |
Gys2 |
glycogen synthase 2 |
|
increases expression |
ISO |
4 |
179,984,036 |
180,018,819 |
RGD:6480464 |
CTD |
| G |
Gys2 |
glycogen synthase 2 |
|
multiple interactions |
ISO |
4 |
179,984,036 |
180,018,819 |
RGD:6480464 |
CTD |
| G |
H19 |
H19, imprinted maternally expressed transcript (non-protein coding) |
|
multiple interactions |
ISO |
1 |
202,822,925 |
202,825,601 |
RGD:6480464 |
CTD |
| G |
H1f0 |
H1 histone family, member 0 |
|
multiple interactions |
ISO |
7 |
117,001,334 |
117,003,194 |
RGD:6480464 |
CTD |
| G |
H1foo |
H1 histone family, member O, oocyte-specific |
|
affects methylation |
ISO |
4 |
152,070,310 |
152,075,730 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
increases phosphorylation |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
affects localization |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
increases expression |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
multiple interactions |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
Has2 |
hyaluronan synthase 2 |
|
affects expression |
ISO |
7 |
93,230,135 |
93,256,139 |
RGD:6480464 |
CTD |
| G |
Hck |
hemopoietic cell kinase |
|
multiple interactions |
ISO |
3 |
143,447,697 |
143,490,281 |
RGD:6480464 |
CTD |
| G |
Hck |
hemopoietic cell kinase |
|
affects methylation |
ISO |
3 |
143,447,697 |
143,490,281 |
RGD:6480464 |
CTD |
| G |
Hck |
hemopoietic cell kinase |
|
increases expression |
ISO |
3 |
143,447,697 |
143,490,281 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
multiple interactions |
ISO |
5 |
148,672,515 |
148,699,810 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
multiple interactions |
ISO |
5 |
148,672,515 |
148,699,810 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
multiple interactions |
ISO |
5 |
148,672,515 |
148,699,810 |
RGD:6480464 |
CTD |
| G |
Hdac2 |
histone deacetylase 2 |
|
decreases expression |
ISO |
20 |
41,162,093 |
41,186,492 |
RGD:6480464 |
CTD |
| G |
Hdgfrp2 |
hepatoma-derived growth factor-related protein 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hdgfrp2 |
hepatoma-derived growth factor-related protein 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hdhd2 |
haloacid dehalogenase-like hydrolase domain containing 2 |
|
multiple interactions |
ISO |
18 |
73,896,018 |
73,948,475 |
RGD:6480464 |
CTD |
| G |
Helb |
helicase (DNA) B |
|
increases expression |
ISO |
7 |
59,311,833 |
59,338,961 |
RGD:6480464 |
CTD |
| G |
Hhip |
Hedgehog-interacting protein |
|
multiple interactions |
ISO |
19 |
29,752,595 |
29,840,439 |
RGD:6480464 |
CTD |
| G |
Hic1 |
hypermethylated in cancer 1 |
|
increases expression |
ISO |
10 |
62,470,736 |
62,476,506 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hist2h2aa3 |
histone cluster 2, H2aa3 |
|
increases expression |
ISO |
2 |
191,052,007 |
191,052,604 |
RGD:6480464 |
CTD |
| G |
Hltf |
helicase-like transcription factor |
|
affects methylation |
ISO |
2 |
105,202,487 |
105,262,107 |
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
decreases expression |
ISO |
2 |
51,737,090 |
51,754,583 |
RGD:6480464 |
CTD |
| G |
Hmha1 |
histocompatibility (minor) HA-1 |
|
increases expression |
ISO |
7 |
11,187,348 |
11,202,717 |
RGD:6480464 |
CTD |
| G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
|
decreases expression |
ISO |
4 |
79,700,327 |
79,704,116 |
RGD:6480464 |
CTD |
| G |
Hnrnpf |
heterogeneous nuclear ribonucleoprotein F |
|
increases expression |
ISO |
4 |
154,207,198 |
154,228,398 |
RGD:6480464 |
CTD |
| G |
Hoxa5 |
homeo box A5 |
|
multiple interactions |
ISO |
4 |
80,501,675 |
80,504,626 |
RGD:6480464 |
CTD |
| G |
Hoxa7 |
homeobox A7 |
|
increases expression |
ISO |
4 |
80,515,622 |
80,517,521 |
RGD:6480464 |
CTD |
| G |
Hoxb13 |
homeo box B13 |
|
affects expression |
ISO |
10 |
84,925,520 |
84,927,793 |
RGD:6480464 |
CTD |
| G |
Hoxb4 |
homeo box B4 |
|
multiple interactions |
ISO |
10 |
85,050,695 |
85,053,277 |
RGD:6480464 |
CTD |
| G |
Hoxd3 |
homeo box D3 |
|
decreases methylation |
ISO |
3 |
57,358,585 |
57,361,651 |
RGD:6480464 |
CTD |
| G |
Hoxd3 |
homeo box D3 |
|
increases expression |
ISO |
3 |
57,358,585 |
57,361,651 |
RGD:6480464 |
CTD |
| G |
Hpcal1 |
hippocalcin-like 1 |
|
multiple interactions |
EXP |
6 |
41,458,062 |
41,576,771 |
RGD:6480464 |
CTD |
| G |
Hps1 |
Hermansky-Pudlak syndrome 1 homolog (human) |
|
affects expression |
ISO |
1 |
248,109,643 |
248,134,450 |
RGD:6480464 |
CTD |
| G |
Hpse |
heparanase |
|
affects expression |
ISO |
14 |
10,144,322 |
10,185,115 |
RGD:6480464 |
CTD |
| G |
Hs3st1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 1 |
|
multiple interactions |
ISO |
14 |
76,438,219 |
76,439,157 |
RGD:6480464 |
CTD |
| G |
Hs3st1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 1 |
|
increases expression |
ISO |
14 |
76,438,219 |
76,439,157 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
increases expression |
ISO |
19 |
35,336,342 |
35,341,585 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
increases expression |
EXP |
19 |
35,336,342 |
35,341,585 |
RGD:6480464 |
CTD |
| G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
|
decreases expression |
ISO |
5 |
77,680,173 |
77,716,789 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
decreases expression |
ISO |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
multiple interactions |
ISO |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
increases expression |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
affects methylation |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
multiple interactions |
ISO |
18 |
27,419,614 |
27,437,031 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
increases response to substance |
ISO |
18 |
27,419,614 |
27,437,031 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
increases expression |
ISO |
18 |
27,419,614 |
27,437,031 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
multiple interactions |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
affects methylation |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam2 |
intercellular adhesion molecule 2 |
|
increases expression |
ISO |
10 |
95,772,448 |
95,779,071 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
increases expression |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
multiple interactions |
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
increases expression |
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
increases expression |
ISO |
5 |
154,934,138 |
154,935,707 |
RGD:6480464 |
CTD |
| G |
Id4 |
inhibitor of DNA binding 4 |
|
increases expression |
ISO |
17 |
22,525,292 |
22,527,861 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
multiple interactions |
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
increases expression |
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ifi27 |
interferon, alpha-inducible protein 27 |
|
increases expression |
ISO |
6 |
127,725,194 |
127,731,665 |
RGD:6480464 |
CTD |
| G |
Ifi30 |
interferon gamma inducible protein 30 |
|
multiple interactions |
ISO |
16 |
19,181,236 |
19,185,438 |
RGD:6480464 |
CTD |
| G |
Ifitm3 |
interferon induced transmembrane protein 3 |
|
increases expression |
ISO |
1 |
201,198,659 |
201,199,768 |
RGD:6480464 |
CTD |
| G |
Ifnb1 |
interferon beta 1, fibroblast |
|
multiple interactions |
ISO |
5 |
107,837,628 |
107,838,182 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases secretion |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ift74 |
intraflagellar transport 74 homolog (Chlamydomonas) |
|
affects expression |
ISO |
5 |
114,913,347 |
115,003,963 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
multiple interactions |
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
multiple interactions |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
increases expression |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
multiple interactions |
ISO |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Igfbp6 |
insulin-like growth factor binding protein 6 |
|
increases expression |
ISO |
7 |
140,885,388 |
140,890,028 |
RGD:6480464 |
CTD |
| G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
|
affects methylation |
ISO |
14 |
33,010,198 |
33,070,055 |
RGD:6480464 |
CTD |
| G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
|
increases expression |
ISO |
14 |
33,010,198 |
33,070,055 |
RGD:6480464 |
CTD |
| G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
|
increases expression |
ISO |
14 |
33,010,198 |
33,070,055 |
RGD:6480464 |
CTD |
| G |
Ikzf3 |
IKAROS family zinc finger 3 |
|
multiple interactions |
ISO |
10 |
87,275,051 |
87,365,273 |
RGD:6480464 |
CTD |
| G |
Ikzf3 |
IKAROS family zinc finger 3 |
|
affects methylation |
ISO |
10 |
87,275,051 |
87,365,273 |
RGD:6480464 |
CTD |
| G |
Il12rb2 |
interleukin 12 receptor, beta 2 |
|
increases expression |
ISO |
4 |
96,929,755 |
96,995,733 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il24 |
interleukin 24 |
|
increases expression |
ISO |
13 |
43,831,510 |
43,836,908 |
RGD:6480464 |
CTD |
| G |
Il24 |
interleukin 24 |
|
affects expression |
ISO |
13 |
43,831,510 |
43,836,908 |
RGD:6480464 |
CTD |
| G |
Il4r |
interleukin 4 receptor |
|
affects expression |
ISO |
1 |
184,612,903 |
184,637,863 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6r |
interleukin 6 receptor |
|
increases expression |
ISO |
2 |
182,078,049 |
182,128,135 |
RGD:6480464 |
CTD |
| G |
Il6st |
interleukin 6 signal transducer |
|
increases expression |
ISO |
2 |
43,806,301 |
43,842,365 |
RGD:6480464 |
CTD |
| G |
Il7r |
interleukin 7 receptor |
|
multiple interactions |
ISO |
2 |
59,103,992 |
59,128,004 |
RGD:6480464 |
CTD |
| G |
Il7r |
interleukin 7 receptor |
|
affects methylation |
ISO |
2 |
59,103,992 |
59,128,004 |
RGD:6480464 |
CTD |
| G |
Il7r |
interleukin 7 receptor |
|
decreases expression |
ISO |
2 |
59,103,992 |
59,128,004 |
RGD:6480464 |
CTD |
| G |
Ing1 |
inhibitor of growth family, member 1 |
|
affects methylation |
ISO |
16 |
82,789,254 |
82,790,319 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
decreases expression |
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insig2 |
insulin induced gene 2 |
|
increases expression |
ISO |
13 |
33,331,951 |
33,345,132 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
increases expression |
ISO |
10 |
39,220,600 |
39,227,602 |
RGD:6480464 |
CTD |
| G |
Irf7 |
interferon regulatory factor 7 |
|
increases expression |
ISO |
1 |
201,456,689 |
201,459,756 |
RGD:6480464 |
CTD |
| G |
Irf7 |
interferon regulatory factor 7 |
|
increases expression |
ISO |
1 |
201,456,689 |
201,459,756 |
RGD:6480464 |
CTD |
| G |
Irf7 |
interferon regulatory factor 7 |
|
multiple interactions |
ISO |
1 |
201,456,689 |
201,459,756 |
RGD:6480464 |
CTD |
| G |
Irf8 |
interferon regulatory factor 8 |
|
multiple interactions |
ISO |
19 |
51,100,088 |
51,116,730 |
RGD:6480464 |
CTD |
| G |
Irs2 |
insulin receptor substrate 2 |
|
increases expression |
ISO |
16 |
83,379,987 |
83,404,220 |
RGD:6480464 |
CTD |
| G |
Irx1 |
iroquois homeobox 1 |
|
multiple interactions |
ISO |
17 |
1,390,894 |
1,396,724 |
RGD:6480464 |
CTD |
| G |
Irx4 |
iroquois homeobox 4 |
|
affects expression |
ISO |
17 |
106,225 |
116,183 |
RGD:6480464 |
CTD |
| G |
Itga1 |
integrin, alpha 1 |
|
affects methylation |
ISO |
2 |
47,107,849 |
47,206,261 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
multiple interactions |
ISO |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
affects expression |
ISO |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
multiple interactions |
ISO |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Jak2 |
Janus kinase 2 |
|
decreases expression |
ISO |
1 |
232,915,995 |
232,974,763 |
RGD:6480464 |
CTD |
| G |
Jak2 |
Janus kinase 2 |
|
decreases methylation |
ISO |
1 |
232,915,995 |
232,974,763 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
affects methylation |
ISO |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
affects expression |
ISO |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Jund |
jun D proto-oncogene |
|
multiple interactions |
ISO |
16 |
19,239,694 |
19,241,529 |
RGD:6480464 |
CTD |
| G |
Jup |
junction plakoglobin |
|
increases expression |
ISO |
10 |
89,307,938 |
89,335,254 |
RGD:6480464 |
CTD |
| G |
Jup |
junction plakoglobin |
|
multiple interactions |
ISO |
10 |
89,307,938 |
89,335,254 |
RGD:6480464 |
CTD |
| G |
Kcnip4 |
Kv channel interacting protein 4 |
|
increases expression |
ISO |
14 |
66,284,290 |
67,452,628 |
RGD:6480464 |
CTD |
| G |
Kcnj13 |
potassium inwardly-rectifying channel, subfamily J, member 13 |
|
affects expression |
ISO |
9 |
86,206,927 |
86,216,659 |
RGD:6480464 |
CTD |
| G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
|
increases expression |
ISO |
4 |
180,144,084 |
180,149,935 |
RGD:6480464 |
CTD |
| G |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
increases expression |
ISO |
1 |
79,613,736 |
79,628,887 |
RGD:6480464 |
CTD |
| G |
Kdelr1 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 |
|
affects methylation |
ISO |
1 |
96,348,396 |
96,359,282 |
RGD:6480464 |
CTD |
| G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
multiple interactions |
ISO |
8 |
20,259,178 |
20,266,351 |
RGD:6480464 |
CTD |
| G |
Kiss1 |
KiSS-1 metastasis-suppressor |
|
increases expression |
ISO |
13 |
46,244,786 |
46,247,288 |
RGD:6480464 |
CTD |
| G |
Kiss1r |
KISS1 receptor |
|
increases expression |
ISO |
7 |
11,297,840 |
11,301,187 |
RGD:6480464 |
CTD |
| G |
Klf10 |
Kruppel-like factor 10 |
|
multiple interactions |
ISO |
7 |
73,821,190 |
73,826,866 |
RGD:6480464 |
CTD |
| G |
Klf5 |
Kruppel-like factor 5 |
|
multiple interactions |
ISO |
15 |
83,103,177 |
83,118,363 |
RGD:6480464 |
CTD |
| G |
Krcc1 |
lysine-rich coiled-coil 1 |
|
increases expression |
ISO |
4 |
104,483,865 |
104,496,846 |
RGD:6480464 |
CTD |
| G |
Krt20 |
keratin 20 |
|
multiple interactions |
ISO |
10 |
88,335,894 |
88,379,899 |
RGD:6480464 |
CTD |
| G |
Krt5 |
keratin 5 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
affects expression |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
multiple interactions |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
L1td1 |
LINE-1 type transposase domain containing 1 |
|
decreases methylation |
ISO |
5 |
119,147,549 |
119,153,767 |
RGD:6480464 |
CTD |
| G |
Lamp3 |
lysosomal-associated membrane protein 3 |
|
multiple interactions |
ISO |
11 |
83,449,326 |
83,476,622 |
RGD:6480464 |
CTD |
| G |
Lamp3 |
lysosomal-associated membrane protein 3 |
|
increases expression |
ISO |
11 |
83,449,326 |
83,476,622 |
RGD:6480464 |
CTD |
| G |
Larp7 |
La ribonucleoprotein domain family, member 7 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Lats1 |
large tumor suppressor kinase 1 |
|
affects methylation |
ISO |
1 |
2,375,233 |
2,383,106 |
RGD:6480464 |
CTD |
| G |
Lats1 |
large tumor suppressor kinase 1 |
|
multiple interactions |
ISO |
1 |
2,375,233 |
2,383,106 |
RGD:6480464 |
CTD |
| G |
Lats2 |
large tumor suppressor 2 |
|
affects methylation |
ISO |
15 |
36,720,000 |
36,761,065 |
RGD:6480464 |
CTD |
| G |
Lats2 |
large tumor suppressor 2 |
|
multiple interactions |
ISO |
15 |
36,720,000 |
36,761,065 |
RGD:6480464 |
CTD |
| G |
Lct |
lactase |
|
increases expression |
ISO |
13 |
40,990,315 |
41,043,388 |
RGD:6480464 |
CTD |
| G |
Lef1 |
lymphoid enhancer binding factor 1 |
|
decreases expression |
ISO |
2 |
228,550,263 |
228,673,131 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases methylation |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases expression |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Letm1 |
leucine zipper-EF-hand containing transmembrane protein 1 |
|
multiple interactions |
ISO |
14 |
82,637,839 |
82,677,419 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
ISO |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lif |
leukemia inhibitory factor |
|
increases expression |
ISO |
14 |
84,887,856 |
84,890,630 |
RGD:6480464 |
CTD |
| G |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
|
increases expression |
ISO |
20 |
37,349,188 |
37,397,427 |
RGD:6480464 |
CTD |
| G |
Lmnb1 |
lamin B1 |
|
decreases expression |
ISO |
18 |
52,470,605 |
52,508,022 |
RGD:6480464 |
CTD |
| G |
Lmnb1 |
lamin B1 |
|
multiple interactions |
ISO |
18 |
52,470,605 |
52,508,022 |
RGD:6480464 |
CTD |
| G |
LOC498675 |
hypothetical LOC498675 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
LOC498675 |
hypothetical LOC498675 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
LOC499602 |
hypothetical protein LOC499602 |
|
decreases expression |
ISO |
2 |
127,822,812 |
127,874,232 |
RGD:6480464 |
CTD |
| G |
LOC499602 |
hypothetical protein LOC499602 |
|
multiple interactions |
ISO |
2 |
127,822,812 |
127,874,232 |
RGD:6480464 |
CTD |
| G |
Lox |
lysyl oxidase |
|
affects expression |
ISO |
18 |
47,896,674 |
47,970,829 |
RGD:6480464 |
CTD |
| G |
Lox |
lysyl oxidase |
|
increases expression |
ISO |
18 |
47,896,674 |
47,970,829 |
RGD:6480464 |
CTD |
| G |
Loxl2 |
lysyl oxidase-like 2 |
|
multiple interactions |
ISO |
15 |
49,982,103 |
50,068,902 |
RGD:6480464 |
CTD |
| G |
Loxl2 |
lysyl oxidase-like 2 |
|
increases expression |
ISO |
15 |
49,982,103 |
50,068,902 |
RGD:6480464 |
CTD |
| G |
Loxl4 |
lysyl oxidase-like 4 |
|
increases expression |
ISO |
1 |
248,269,249 |
248,287,588 |
RGD:6480464 |
CTD |
| G |
Lpar1 |
lysophosphatidic acid receptor 1 |
|
multiple interactions |
ISO |
5 |
76,449,470 |
76,571,458 |
RGD:6480464 |
CTD |
| G |
Lpxn |
leupaxin |
|
increases expression |
ISO |
1 |
215,885,954 |
215,920,253 |
RGD:6480464 |
CTD |
| G |
Lrch4 |
leucine-rich repeats and calponin homology (CH) domain containing 4 |
|
increases expression |
ISO |
12 |
19,694,434 |
19,705,423 |
RGD:6480464 |
CTD |
| G |
Lrrc2 |
leucine rich repeat containing 2 |
|
multiple interactions |
ISO |
8 |
115,355,358 |
115,387,125 |
RGD:6480464 |
CTD |
| G |
Lrrc2 |
leucine rich repeat containing 2 |
|
increases expression |
ISO |
8 |
115,355,358 |
115,387,125 |
RGD:6480464 |
CTD |
| G |
Lrrc2 |
leucine rich repeat containing 2 |
|
affects expression |
ISO |
8 |
115,355,358 |
115,387,125 |
RGD:6480464 |
CTD |
| G |
Lrrc23 |
leucine rich repeat containing 23 |
|
increases expression |
ISO |
4 |
160,899,357 |
160,909,547 |
RGD:6480464 |
CTD |
| G |
Lst1 |
leukocyte specific transcript 1 |
|
increases expression |
ISO |
20 |
3,698,568 |
3,701,564 |
RGD:6480464 |
CTD |
| G |
Lxn |
latexin |
|
affects expression |
ISO |
2 |
157,310,036 |
157,315,905 |
RGD:6480464 |
CTD |
| G |
Mael |
maelstrom spermatogenic transposon silencer |
|
increases expression |
ISO |
13 |
81,935,141 |
81,975,026 |
RGD:6480464 |
CTD |
| G |
Maf |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) |
|
affects expression |
ISO |
19 |
45,859,510 |
45,861,454 |
RGD:6480464 |
CTD |
| G |
Magea9 |
melanoma antigen, family A, 9 |
|
affects expression |
ISO |
X |
158,876,037 |
158,876,825 |
RGD:6480464 |
CTD |
| G |
Magea9 |
melanoma antigen, family A, 9 |
|
increases expression |
ISO |
X |
158,876,037 |
158,876,825 |
RGD:6480464 |
CTD |
| G |
Mageb2 |
melanoma antigen family B, 2 |
|
increases expression |
ISO |
X |
73,077,761 |
73,079,281 |
RGD:6480464 |
CTD |
| G |
Mal |
mal, T-cell differentiation protein |
|
increases expression |
ISO |
3 |
115,166,671 |
115,190,432 |
RGD:6480464 |
CTD |
| G |
Mal |
mal, T-cell differentiation protein |
|
decreases methylation |
ISO |
3 |
115,166,671 |
115,190,432 |
RGD:6480464 |
CTD |
| G |
Man1b1 |
mannosidase, alpha, class 1B, member 1 |
|
increases expression |
ISO |
3 |
3,493,476 |
3,514,884 |
RGD:6480464 |
CTD |
| G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
|
multiple interactions |
ISO |
19 |
51,847,187 |
51,854,858 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
increases expression |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map3k3 |
mitogen activated protein kinase kinase kinase 3 |
|
multiple interactions |
ISO |
10 |
95,482,303 |
95,551,065 |
RGD:6480464 |
CTD |
| G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
|
decreases expression |
ISO |
17 |
61,910,179 |
61,930,459 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapkapk2 |
mitogen-activated protein kinase-activated protein kinase 2 |
|
affects methylation |
ISO |
13 |
43,994,943 |
44,041,504 |
RGD:6480464 |
CTD |
| G |
Mapre3 |
microtubule-associated protein, RP/EB family, member 3 |
|
multiple interactions |
ISO |
6 |
25,496,282 |
25,506,449 |
RGD:6480464 |
CTD |
| G |
Mark1 |
MAP/microtubule affinity-regulating kinase 1 |
|
increases expression |
ISO |
13 |
100,905,369 |
101,009,161 |
RGD:6480464 |
CTD |
| G |
Masp1 |
mannan-binding lectin serine peptidase 1 |
|
decreases expression |
ISO |
11 |
79,532,504 |
79,602,755 |
RGD:6480464 |
CTD |
| G |
Mbd1 |
methyl-CpG binding domain protein 1 |
|
increases expression |
ISO |
18 |
71,068,257 |
71,082,734 |
RGD:6480464 |
CTD |
| G |
Mbd2 |
methyl-CpG binding domain protein 2 |
|
multiple interactions |
ISO |
18 |
67,281,440 |
67,348,558 |
RGD:6480464 |
CTD |
| G |
Mbd2 |
methyl-CpG binding domain protein 2 |
|
multiple interactions |
ISO |
18 |
67,281,440 |
67,348,558 |
RGD:6480464 |
CTD |
| G |
Mbd2 |
methyl-CpG binding domain protein 2 |
|
decreases activity |
ISO |
18 |
67,281,440 |
67,348,558 |
RGD:6480464 |
CTD |
| G |
Mbd3l2 |
methyl-CpG binding domain protein 3-like 2 |
|
increases expression |
ISO |
8 |
15,975,721 |
15,977,070 |
RGD:6480464 |
CTD |
| G |
Mcm4 |
minichromosome maintenance complex component 4 |
|
affects methylation |
ISO |
11 |
87,169,742 |
87,183,443 |
RGD:6480464 |
CTD |
| G |
Mcm5 |
minichromosome maintenance complex component 5 |
|
affects methylation |
ISO |
19 |
13,978,940 |
14,000,641 |
RGD:6480464 |
CTD |
| G |
Mcm7 |
minichromosome maintenance complex component 7 |
|
affects methylation |
ISO |
12 |
17,607,250 |
17,614,508 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
affects expression |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mecp2 |
methyl CpG binding protein 2 |
|
multiple interactions |
ISO |
X |
159,980,599 |
160,035,260 |
RGD:6480464 |
CTD |
| G |
Mecr |
mitochondrial trans-2-enoyl-CoA reductase |
|
increases expression |
ISO |
5 |
150,700,130 |
150,725,219 |
RGD:6480464 |
CTD |
| G |
Mef2c |
myocyte enhancer factor 2C |
|
increases expression |
ISO |
2 |
12,331,078 |
12,346,520 |
RGD:6480464 |
CTD |
| G |
Mettl7a |
methyltransferase like 7A |
|
increases expression |
ISO |
7 |
139,062,222 |
139,062,833 |
RGD:6480464 |
CTD |
| G |
Mfap2 |
microfibrillar-associated protein 2 |
|
affects expression |
ISO |
5 |
159,868,933 |
159,874,481 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases methylation |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases expression |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
increases expression |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mia |
melanoma inhibitory activity |
|
increases expression |
ISO |
1 |
82,255,458 |
82,257,125 |
RGD:6480464 |
CTD |
| G |
Micb |
MHC class I polypeptide-related sequence B |
|
multiple interactions |
ISO |
1 |
78,199,668 |
78,216,687 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases expression |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nipsnap1 |
nipsnap homolog 1 (C. elegans) |
|
affects expression |
ISO |
14 |
85,532,437 |
85,556,559 |
RGD:6480464 |
CTD |
| G |
Nkx2-1 |
NK2 homeobox 1 |
|
multiple interactions |
ISO |
6 |
76,916,943 |
76,920,133 |
RGD:6480464 |
CTD |
| G |
Nkx2-1 |
NK2 homeobox 1 |
|
affects expression |
ISO |
6 |
76,916,943 |
76,920,133 |
RGD:6480464 |
CTD |
| G |
Nkx2-1 |
NK2 homeobox 1 |
|
increases expression |
ISO |
6 |
76,916,943 |
76,920,133 |
RGD:6480464 |
CTD |
| G |
Nkx2-8 |
NK2 homeobox 8 |
|
increases expression |
ISO |
6 |
77,007,954 |
77,009,657 |
RGD:6480464 |
CTD |
| G |
Nkx3-1 |
NK3 homeobox 1 |
|
increases expression |
ISO |
15 |
49,743,313 |
49,745,905 |
RGD:6480464 |
CTD |
| G |
Nmb |
neuromedin B |
|
increases expression |
ISO |
1 |
137,097,463 |
137,100,207 |
RGD:6480464 |
CTD |
| G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
affects methylation |
ISO |
10 |
82,582,766 |
82,588,269 |
RGD:6480464 |
CTD |
| G |
Nnat |
neuronatin |
|
increases expression |
ISO |
3 |
148,269,404 |
148,271,781 |
RGD:6480464 |
CTD |
| G |
Nnat |
neuronatin |
|
multiple interactions |
EXP |
3 |
148,269,404 |
148,271,781 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Notch1 |
notch 1 |
|
multiple interactions |
ISO |
3 |
4,631,797 |
4,677,640 |
RGD:6480464 |
CTD |
| G |
Npas4 |
neuronal PAS domain protein 4 |
|
increases expression |
ISO |
1 |
207,597,735 |
207,602,499 |
RGD:6480464 |
CTD |
| G |
Npm1 |
nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
|
decreases methylation |
ISO |
10 |
18,051,990 |
18,062,714 |
RGD:6480464 |
CTD |
| G |
Npm2 |
nucleophosmin/nucleoplasmin 2 |
|
decreases methylation |
ISO |
15 |
51,049,549 |
51,056,301 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
decreases methylation |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
|
decreases expression |
ISO |
2 |
5,765,399 |
5,794,104 |
RGD:6480464 |
CTD |
| G |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
|
multiple interactions |
ISO |
2 |
5,765,399 |
5,794,104 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
decreases expression |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
increases expression |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr5a1 |
nuclear receptor subfamily 5, group A, member 1 |
|
affects methylation |
ISO |
3 |
18,498,913 |
18,519,738 |
RGD:6480464 |
CTD |
| G |
Nrbp |
nuclear receptor binding protein |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Nrcam |
neuronal cell adhesion molecule |
|
affects expression |
ISO |
6 |
63,717,460 |
64,015,522 |
RGD:6480464 |
CTD |
| G |
Nrp1 |
neuropilin 1 |
|
multiple interactions |
ISO |
19 |
58,332,004 |
58,487,686 |
RGD:6480464 |
CTD |
| G |
Nrtn |
neurturin |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Nrtn |
neurturin |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Nt5e |
5' nucleotidase, ecto |
|
increases expression |
ISO |
8 |
93,591,630 |
93,635,481 |
RGD:6480464 |
CTD |
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
increases expression |
ISO |
17 |
11,494,463 |
11,811,654 |
RGD:6480464 |
CTD |
| G |
Nubp2 |
nucleotide binding protein 2 |
|
increases expression |
ISO |
10 |
14,131,309 |
14,134,994 |
RGD:6480464 |
CTD |
| G |
Numa1 |
nuclear mitotic apparatus protein 1 |
|
multiple interactions |
ISO |
1 |
159,419,804 |
159,470,987 |
RGD:6480464 |
CTD |
| G |
Numa1 |
nuclear mitotic apparatus protein 1 |
|
decreases expression |
ISO |
1 |
159,419,804 |
159,470,987 |
RGD:6480464 |
CTD |
| G |
Nxph4 |
neurexophilin 4 |
|
decreases expression |
ISO |
7 |
67,502,668 |
67,516,839 |
RGD:6480464 |
CTD |
| G |
Nxph4 |
neurexophilin 4 |
|
multiple interactions |
ISO |
7 |
67,502,668 |
67,516,839 |
RGD:6480464 |
CTD |
| G |
Nxt2 |
nuclear transport factor 2-like export factor 2 |
|
increases expression |
ISO |
X |
36,312,609 |
36,318,816 |
RGD:6480464 |
CTD |
| G |
Oas2 |
2'-5' oligoadenylate synthetase 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ola1 |
Obg-like ATPase 1 |
|
multiple interactions |
ISO |
3 |
55,596,308 |
55,715,568 |
RGD:6480464 |
CTD |
| G |
Ola1 |
Obg-like ATPase 1 |
|
decreases expression |
ISO |
3 |
55,596,308 |
55,715,568 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
affects methylation |
ISO |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
multiple interactions |
ISO |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Osmr |
oncostatin M receptor |
|
increases expression |
ISO |
2 |
56,080,700 |
56,121,463 |
RGD:6480464 |
CTD |
| G |
Osmr |
oncostatin M receptor |
|
multiple interactions |
ISO |
2 |
56,080,700 |
56,121,463 |
RGD:6480464 |
CTD |
| G |
P4ha2 |
prolyl 4-hydroxylase, alpha polypeptide II |
|
increases expression |
ISO |
10 |
39,522,157 |
39,551,063 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pax4 |
paired box 4 |
|
affects expression |
ISO |
4 |
55,313,500 |
55,318,995 |
RGD:6480464 |
CTD |
| G |
Pax6 |
paired box 6 |
|
increases expression |
ISO |
3 |
91,127,605 |
91,149,178 |
RGD:6480464 |
CTD |
| G |
Pcaf |
p300/CBP-associated factor |
|
multiple interactions |
ISO |
9 |
882,928 |
889,661 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
affects methylation |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Prox1 |
prospero homeobox 1 |
|
increases expression |
ISO |
13 |
106,421,541 |
106,471,350 |
RGD:6480464 |
CTD |
| G |
Psip1 |
PC4 and SFRS1 interacting protein 1 |
|
multiple interactions |
ISO |
5 |
102,304,948 |
102,336,608 |
RGD:6480464 |
CTD |
| G |
Psmb4 |
proteasome (prosome, macropain) subunit, beta type 4 |
|
multiple interactions |
ISO |
2 |
189,778,476 |
189,781,169 |
RGD:6480464 |
CTD |
| G |
Psmb4 |
proteasome (prosome, macropain) subunit, beta type 4 |
|
decreases expression |
ISO |
2 |
189,778,476 |
189,781,169 |
RGD:6480464 |
CTD |
| G |
Pstpip1 |
proline-serine-threonine phosphatase-interacting protein 1 |
|
increases expression |
ISO |
8 |
59,693,306 |
59,732,477 |
RGD:6480464 |
CTD |
| G |
Ptch1 |
patched 1 |
|
multiple interactions |
ISO |
17 |
7,088,234 |
7,142,459 |
RGD:6480464 |
CTD |
| G |
Ptch1 |
patched 1 |
|
multiple interactions |
ISO |
17 |
7,088,234 |
7,142,459 |
RGD:6480464 |
CTD |
| G |
Ptch1 |
patched 1 |
|
decreases methylation |
ISO |
17 |
7,088,234 |
7,142,459 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
multiple interactions |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
multiple interactions |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
decreases methylation |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
increases expression |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Ptges |
prostaglandin E synthase |
|
multiple interactions |
ISO |
3 |
9,946,194 |
9,957,538 |
RGD:6480464 |
CTD |
| G |
Ptges |
prostaglandin E synthase |
|
increases expression |
ISO |
3 |
9,946,194 |
9,957,538 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
affects expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
|
decreases methylation |
ISO |
4 |
160,843,699 |
160,868,856 |
RGD:6480464 |
CTD |
| G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
|
increases expression |
ISO |
4 |
160,843,699 |
160,868,856 |
RGD:6480464 |
CTD |
| G |
Ptpn9 |
protein tyrosine phosphatase, non-receptor type 9 |
|
decreases expression |
ISO |
8 |
60,737,741 |
60,817,948 |
RGD:6480464 |
CTD |
| G |
Ptpn9 |
protein tyrosine phosphatase, non-receptor type 9 |
|
multiple interactions |
ISO |
8 |
60,737,741 |
60,817,948 |
RGD:6480464 |
CTD |
| G |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
|
affects methylation |
ISO |
15 |
14,449,352 |
15,130,760 |
RGD:6480464 |
CTD |
| G |
Pxdc1 |
PX domain containing 1 |
|
increases expression |
ISO |
17 |
36,613,791 |
36,642,260 |
RGD:6480464 |
CTD |
| G |
Pxdn |
peroxidasin homolog (Drosophila) |
|
multiple interactions |
ISO |
6 |
47,878,710 |
47,914,112 |
RGD:6480464 |
CTD |
| G |
Pycard |
PYD and CARD domain containing |
|
increases expression |
ISO |
1 |
187,276,089 |
187,277,122 |
RGD:6480464 |
CTD |
| G |
Pycard |
PYD and CARD domain containing |
|
multiple interactions |
ISO |
1 |
187,276,089 |
187,277,122 |
RGD:6480464 |
CTD |
| G |
Pycard |
PYD and CARD domain containing |
|
affects methylation |
ISO |
1 |
187,276,089 |
187,277,122 |
RGD:6480464 |
CTD |
| G |
Pycard |
PYD and CARD domain containing |
|
multiple interactions |
ISO |
1 |
187,276,089 |
187,277,122 |
RGD:6480464 |
CTD |
| G |
Qpct |
glutaminyl-peptide cyclotransferase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Qpct |
glutaminyl-peptide cyclotransferase |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rab13 |
RAB13, member RAS oncogene family |
|
increases expression |
ISO |
2 |
182,460,998 |
182,465,393 |
RGD:6480464 |
CTD |
| G |
Rab13 |
RAB13, member RAS oncogene family |
|
decreases methylation |
ISO |
2 |
182,460,998 |
182,465,393 |
RGD:6480464 |
CTD |
| G |
Rab5c |
RAB5C, member RAS oncogene family |
|
increases expression |
ISO |
10 |
89,652,342 |
89,675,787 |
RGD:6480464 |
CTD |
| G |
Rac2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
|
affects expression |
ISO |
7 |
116,520,066 |
116,532,482 |
RGD:6480464 |
CTD |
| G |
Rad17 |
RAD17 homolog (S. pombe) |
|
decreases expression |
ISO |
2 |
31,424,504 |
31,454,313 |
RGD:6480464 |
CTD |
| G |
Rad23b |
RAD23 homolog B (S. cerevisiae) |
|
multiple interactions |
ISO |
5 |
73,256,542 |
73,294,296 |
RGD:6480464 |
CTD |
| G |
Rad51 |
RAD51 homolog (S. cerevisiae) |
|
affects localization |
ISO |
3 |
105,625,265 |
105,650,392 |
RGD:6480464 |
CTD |
| G |
Rag1 |
recombination activating gene 1 |
|
increases expression |
ISO |
3 |
86,780,782 |
86,791,878 |
RGD:6480464 |
CTD |
| G |
Ralgds |
ral guanine nucleotide dissociation stimulator |
|
affects expression |
ISO |
3 |
7,516,054 |
7,537,651 |
RGD:6480464 |
CTD |
| G |
Ramp2 |
receptor (G protein-coupled) activity modifying protein 2 |
|
affects methylation |
ISO |
10 |
90,275,463 |
90,277,242 |
RGD:6480464 |
CTD |
| G |
Ramp3 |
receptor (G protein-coupled) activity modifying protein 3 |
|
multiple interactions |
ISO |
14 |
87,417,290 |
87,434,789 |
RGD:6480464 |
CTD |
| G |
Ran |
RAN, member RAS oncogene family |
|
multiple interactions |
ISO |
12 |
28,736,786 |
28,739,921 |
RGD:6480464 |
CTD |
| G |
Ran |
RAN, member RAS oncogene family |
|
affects expression |
ISO |
12 |
28,736,786 |
28,739,921 |
RGD:6480464 |
CTD |
| G |
Rangap1 |
RAN GTPase activating protein 1 |
|
increases expression |
ISO |
7 |
120,056,065 |
120,080,018 |
RGD:6480464 |
CTD |
| G |
Rap1gap |
Rap1 GTPase-activating protein |
|
decreases methylation |
ISO |
5 |
156,468,558 |
156,489,592 |
RGD:6480464 |
CTD |
| G |
Rap1gap |
Rap1 GTPase-activating protein |
|
increases expression |
ISO |
5 |
156,468,558 |
156,489,592 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
multiple interactions |
ISO |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
RGD1311892 |
similar to hypothetical protein FLJ10901 |
|
increases expression |
ISO |
13 |
49,249,247 |
49,269,528 |
RGD:6480464 |
CTD |
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
multiple interactions |
ISO |
20 |
1,412,553 |
1,416,692 |
RGD:6480464 |
CTD |
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
multiple interactions |
ISO |
20 |
1,412,553 |
1,416,692 |
RGD:6480464 |
CTD |
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
increases expression |
ISO |
20 |
1,412,553 |
1,416,692 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
multiple interactions |
ISO |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
S100a3 |
S100 calcium binding protein A3 |
|
affects methylation |
ISO |
2 |
182,881,054 |
182,883,821 |
RGD:6480464 |
CTD |
| G |
S100a3 |
S100 calcium binding protein A3 |
|
multiple interactions |
ISO |
2 |
182,881,054 |
182,883,821 |
RGD:6480464 |
CTD |
| G |
S100a3 |
S100 calcium binding protein A3 |
|
increases expression |
ISO |
2 |
182,881,054 |
182,883,821 |
RGD:6480464 |
CTD |
| G |
S100a4 |
S100 calcium-binding protein A4 |
|
affects methylation |
ISO |
2 |
182,885,070 |
182,887,380 |
RGD:6480464 |
CTD |
| G |
S100a4 |
S100 calcium-binding protein A4 |
|
increases expression |
ISO |
2 |
182,885,070 |
182,887,380 |
RGD:6480464 |
CTD |
| G |
S100a5 |
S100 calcium binding protein A5 |
|
increases expression |
ISO |
2 |
182,891,664 |
182,893,671 |
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 |
|
affects methylation |
ISO |
2 |
182,895,080 |
182,896,305 |
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 |
|
increases expression |
ISO |
2 |
182,895,080 |
182,896,305 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 |
|
affects expression |
ISO |
2 |
182,961,994 |
182,962,513 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 |
|
affects expression |
ISO |
2 |
182,985,466 |
182,988,147 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 |
|
increases expression |
ISO |
2 |
182,985,466 |
182,988,147 |
RGD:6480464 |
CTD |
| G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
|
multiple interactions |
ISO |
2 |
211,851,304 |
211,855,511 |
RGD:6480464 |
CTD |
| G |
S1pr2 |
sphingosine-1-phosphate receptor 2 |
|
multiple interactions |
ISO |
8 |
19,989,867 |
20,000,759 |
RGD:6480464 |
CTD |
| G |
S1pr3 |
sphingosine-1-phosphate receptor 3 |
|
multiple interactions |
ISO |
17 |
19,657,822 |
19,661,106 |
RGD:6480464 |
CTD |
| G |
Samd5 |
sterile alpha motif domain containing 5 |
|
decreases expression |
ISO |
1 |
4,269,126 |
4,333,486 |
RGD:6480464 |
CTD |
| G |
Samd5 |
sterile alpha motif domain containing 5 |
|
multiple interactions |
ISO |
1 |
4,269,126 |
4,333,486 |
RGD:6480464 |
CTD |
| G |
Sash3 |
SAM and SH3 domain containing 3 |
|
increases expression |
ISO |
X |
134,511,776 |
134,526,489 |
RGD:6480464 |
CTD |
| G |
Satb1 |
SATB homeobox 1 |
|
affects expression |
ISO |
9 |
3,307,651 |
3,391,348 |
RGD:6480464 |
CTD |
| G |
Scand1 |
SCAN domain-containing 1 |
|
increases expression |
ISO |
3 |
146,710,153 |
146,711,017 |
RGD:6480464 |
CTD |
| G |
Scara3 |
scavenger receptor class A, member 3 |
|
decreases methylation |
ISO |
15 |
45,344,539 |
45,377,576 |
RGD:6480464 |
CTD |
| G |
Scg5 |
secretogranin V (7B2 protein) |
|
increases expression |
ISO |
3 |
99,629,194 |
99,674,523 |
RGD:6480464 |
CTD |
| G |
Scgb3a1 |
secretoglobin, family 3A, member 1 |
|
decreases methylation |
ISO |
10 |
35,125,569 |
35,126,876 |
RGD:6480464 |
CTD |
| G |
Scgb3a1 |
secretoglobin, family 3A, member 1 |
|
increases expression |
ISO |
10 |
35,125,569 |
35,126,876 |
RGD:6480464 |
CTD |
| G |
Scpep1 |
serine carboxypeptidase 1 |
|
multiple interactions |
ISO |
10 |
77,347,473 |
77,377,945 |
RGD:6480464 |
CTD |
| G |
Scpep1 |
serine carboxypeptidase 1 |
|
decreases expression |
ISO |
10 |
77,347,473 |
77,377,945 |
RGD:6480464 |
CTD |
| G |
Scrn1 |
secernin 1 |
|
increases expression |
ISO |
4 |
82,912,923 |
82,971,950 |
RGD:6480464 |
CTD |
| G |
Sdc2 |
syndecan 2 |
|
affects expression |
ISO |
7 |
68,290,558 |
68,405,183 |
RGD:6480464 |
CTD |
| G |
Sdc4 |
syndecan 4 |
|
increases expression |
ISO |
3 |
155,446,138 |
155,464,825 |
RGD:6480464 |
CTD |
| G |
Sel1l |
sel-1 suppressor of lin-12-like (C. elegans) |
|
multiple interactions |
ISO |
6 |
115,431,169 |
115,472,901 |
RGD:6480464 |
CTD |
| G |
Sel1l |
sel-1 suppressor of lin-12-like (C. elegans) |
|
decreases expression |
ISO |
6 |
115,431,169 |
115,472,901 |
RGD:6480464 |
CTD |
| G |
Sell |
selectin L |
|
increases expression |
ISO |
13 |
79,827,342 |
79,845,296 |
RGD:6480464 |
CTD |
| G |
Semg1 |
semenogelin I |
|
affects expression |
ISO |
3 |
155,179,283 |
155,182,131 |
RGD:6480464 |
CTD |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
affects expression |
ISO |
2 |
52,451,883 |
52,462,263 |
RGD:6480464 |
CTD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
increases expression |
ISO |
6 |
127,998,617 |
128,021,719 |
RGD:6480464 |
CTD |
| G |
Serpinb2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
increases expression |
ISO |
13 |
13,632,596 |
13,641,605 |
RGD:6480464 |
CTD |
| G |
Serpinb5 |
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
|
affects expression |
ISO |
13 |
13,037,587 |
13,057,785 |
RGD:6480464 |
CTD |
| G |
Serpinb5 |
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
|
multiple interactions |
ISO |
13 |
13,037,587 |
13,057,785 |
RGD:6480464 |
CTD |
| G |
Serpinb5 |
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
|
increases expression |
ISO |
13 |
13,037,587 |
13,057,785 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
multiple interactions |
ISO |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
multiple interactions |
ISO |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
multiple interactions |
ISO |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
increases expression |
ISO |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
increases expression |
ISO |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
multiple interactions |
ISO |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Sp110 |
SP110 nuclear body protein |
|
increases expression |
ISO |
9 |
84,258,232 |
84,279,462 |
RGD:6480464 |
CTD |
| G |
Sp3 |
Sp3 transcription factor |
|
multiple interactions |
ISO |
3 |
55,440,985 |
55,485,768 |
RGD:6480464 |
CTD |
| G |
Sp3 |
Sp3 transcription factor |
|
multiple interactions |
ISO |
3 |
55,440,985 |
55,485,768 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
multiple interactions |
ISO |
10 |
40,809,730 |
40,831,481 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
multiple interactions |
ISO |
10 |
40,809,730 |
40,831,481 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
increases expression |
ISO |
10 |
40,809,730 |
40,831,481 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
increases expression |
ISO |
10 |
40,809,730 |
40,831,481 |
RGD:6480464 |
CTD |
| G |
Sphk1 |
sphingosine kinase 1 |
|
increases expression |
ISO |
10 |
106,641,509 |
106,645,579 |
RGD:6480464 |
CTD |
| G |
Spi1 |
spleen focus forming virus (SFFV) proviral integration oncogene spi1 |
|
affects methylation |
ISO |
3 |
75,456,353 |
75,475,722 |
RGD:6480464 |
CTD |
| G |
Sprr1a |
small proline-rich protein 1A |
|
increases expression |
ISO |
2 |
185,463,951 |
185,465,849 |
RGD:6480464 |
CTD |
| G |
Sptan1 |
spectrin, alpha, non-erythrocytic 1 |
|
multiple interactions |
ISO |
3 |
8,956,380 |
9,021,831 |
RGD:6480464 |
CTD |
| G |
Spz1 |
spermatogenic leucine zipper 1 |
|
increases expression |
ISO |
2 |
22,809,373 |
22,810,969 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
multiple interactions |
ISO |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srgn |
serglycin |
|
increases expression |
ISO |
20 |
29,746,729 |
29,761,072 |
RGD:6480464 |
CTD |
| G |
Sri |
sorcin |
|
affects methylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ssbp2 |
single-stranded DNA binding protein 2 |
|
multiple interactions |
ISO |
2 |
21,651,784 |
21,926,781 |
RGD:6480464 |
CTD |
| G |
Ssbp2 |
single-stranded DNA binding protein 2 |
|
increases expression |
ISO |
2 |
21,651,784 |
21,926,781 |
RGD:6480464 |
CTD |
| G |
Sst |
somatostatin |
|
affects methylation |
ISO |
11 |
79,125,031 |
79,126,216 |
RGD:6480464 |
CTD |
| G |
Sstr5 |
somatostatin receptor 5 |
|
multiple interactions |
ISO |
10 |
14,740,991 |
14,747,069 |
RGD:6480464 |
CTD |
| G |
Ssx1 |
synovial sarcoma, X breakpoint 1 |
|
affects expression |
ISO |
X |
26,091,234 |
26,096,666 |
RGD:6480464 |
CTD |
| G |
Ssx1 |
synovial sarcoma, X breakpoint 1 |
|
increases expression |
ISO |
X |
26,091,234 |
26,096,666 |
RGD:6480464 |
CTD |
| G |
Stard5 |
StAR-related lipid transfer (START) domain containing 5 |
|
multiple interactions |
ISO |
1 |
139,896,268 |
139,906,134 |
RGD:6480464 |
CTD |
| G |
Stard5 |
StAR-related lipid transfer (START) domain containing 5 |
|
decreases expression |
ISO |
1 |
139,896,268 |
139,906,134 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
multiple interactions |
ISO |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Stc2 |
stanniocalcin 2 |
|
multiple interactions |
ISO |
10 |
16,514,603 |
16,524,369 |
RGD:6480464 |
CTD |
| G |
Stk17b |
serine/threonine kinase 17b |
|
multiple interactions |
ISO |
9 |
52,567,310 |
52,596,817 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases methylation |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases acetylation |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases ubiquitination |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases phosphorylation |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
|
multiple interactions |
ISO |
5 |
25,008,253 |
25,014,263 |
RGD:6480464 |
CTD |
| G |
Tp73 |
tumor protein p73 |
|
decreases methylation |
ISO |
5 |
170,848,979 |
171,078,739 |
RGD:6480464 |
CTD |
| G |
Tpm2 |
tropomyosin 2, beta |
|
affects expression |
ISO |
5 |
59,994,101 |
60,003,261 |
RGD:6480464 |
CTD |
| G |
Tpm4 |
tropomyosin 4 |
|
decreases expression |
ISO |
16 |
18,108,914 |
18,122,956 |
RGD:6480464 |
CTD |
| G |
Tpt1 |
tumor protein, translationally-controlled 1 |
|
decreases expression |
ISO |
15 |
56,752,464 |
56,755,288 |
RGD:6480464 |
CTD |
| G |
Tpt1 |
tumor protein, translationally-controlled 1 |
|
multiple interactions |
ISO |
15 |
56,752,464 |
56,755,288 |
RGD:6480464 |
CTD |
| G |
Trim10 |
tripartite motif-containing 10 |
|
decreases expression |
ISO |
20 |
1,781,869 |
1,790,921 |
RGD:6480464 |
CTD |
| G |
Trim23 |
tripartite motif-containing 23 |
|
increases expression |
ISO |
2 |
35,101,019 |
35,135,028 |
RGD:6480464 |
CTD |
| G |
Trim8 |
tripartite motif-containing 8 |
|
increases expression |
ISO |
1 |
251,724,890 |
251,739,787 |
RGD:6480464 |
CTD |
| G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
|
decreases expression |
ISO |
20 |
11,053,301 |
11,099,740 |
RGD:6480464 |
CTD |
| G |
Ttbk2 |
tau tubulin kinase 2 |
|
affects expression |
ISO |
3 |
107,517,280 |
107,623,425 |
RGD:6480464 |
CTD |
| G |
Tubb2a |
tubulin, beta 2A class IIa |
|
multiple interactions |
ISO |
17 |
37,139,177 |
37,143,049 |
RGD:6480464 |
CTD |
| G |
Tubb2b |
tubulin, beta 2B class IIb |
|
increases expression |
ISO |
17 |
37,087,922 |
37,090,969 |
RGD:6480464 |
CTD |
| G |
Tubb3 |
tubulin, beta 3 class III |
|
affects expression |
ISO |
19 |
53,742,652 |
53,751,706 |
RGD:6480464 |
CTD |
| G |
Tubb3 |
tubulin, beta 3 class III |
|
multiple interactions |
ISO |
19 |
53,742,652 |
53,751,706 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
increases expression |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Tyrobp |
Tyro protein tyrosine kinase binding protein |
|
multiple interactions |
ISO |
1 |
85,365,371 |
85,369,224 |
RGD:6480464 |
CTD |
| G |
Tyrobp |
Tyro protein tyrosine kinase binding protein |
|
decreases expression |
ISO |
1 |
85,365,371 |
85,369,224 |
RGD:6480464 |
CTD |
| G |
Ubac1 |
UBA domain containing 1 |
|
increases expression |
ISO |
3 |
4,178,964 |
4,201,546 |
RGD:6480464 |
CTD |
| G |
Ubxn6 |
UBX domain protein 6 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Uchl1 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
|
multiple interactions |
ISO |
14 |
44,114,392 |
44,124,947 |
RGD:6480464 |
CTD |
| G |
Uchl1 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
|
increases expression |
ISO |
14 |
44,114,392 |
44,124,947 |
RGD:6480464 |
CTD |
| G |
Vamp8 |
vesicle-associated membrane protein 8 |
|
affects expression |
ISO |
4 |
105,692,451 |
105,694,908 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
multiple interactions |
ISO |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
affects expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
affects methylation |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vimp |
VCP-interacting membrane protein |
|
multiple interactions |
ISO |
1 |
120,509,100 |
120,518,867 |
RGD:6480464 |
CTD |
| G |
Vimp |
VCP-interacting membrane protein |
|
decreases expression |
ISO |
1 |
120,509,100 |
120,518,867 |
RGD:6480464 |
CTD |
Term paths to the root
|